|
Top 10 proteins (for # mutations) |
Top 10 proteins
| Uniprot AC
| Muts
| Diseases
| Ints
|
F8 |
P00451 |
472 |
1 |
15 |
SCN1A |
P35498 |
377 |
4 |
2 |
FBN1 |
P35555 |
352 |
6 |
16 |
PAH |
P00439 |
206 |
2 |
3 |
MYH7 |
P12883 |
200 |
4 |
19 |
ABCA4 |
P78363 |
197 |
4 |
1 |
GJB1 |
P08034 |
188 |
2 |
48 |
ATP7B |
P35670 |
184 |
1 |
7 |
GLA |
P06280 |
180 |
1 |
4 |
GBA |
P04062 |
162 |
1 |
3 |
|
Diseases with potential edgetic perturbations |
Disease | Phenotype | Relevant proteins |
ADULT syndrome |
Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285] |
TP63 |
ARTS syndrome |
ARTS syndrome (ARTS) [MIM:301835] |
PRPS1 |
Achondroplasia |
Achondroplasia (ACH) [MIM:100800] |
FGFR3 |
Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM:616482] |
FGFR3 |
Acne |
Acne inversa, familial, 1 (ACNINV1) [MIM:142690] |
NCSTN |
Acrodysostosis |
Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800] |
PRKAR1A |
Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613] |
PDE4D |
Acyl-CoA dehydrogenase deficiency |
Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
ACADM |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
GNAS |
Adrenal hypoplasia, congenital (AHC) [MIM:300200] |
NR0B1 |
Adrenal insufficiency, NR5A1-related |
Adrenal insufficiency, NR5A1-related (AINR) [MIM:612964] |
NR5A1 |
Afibrinogenemia |
Congenital afibrinogenemia (CAFBN) [MIM:202400] |
FGG, FGA, FGB |
Agammaglobulinemia |
Agammaglobulinemia 2, autosomal recessive (AGM2) [MIM:613500] |
IGLL1 |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
BTK |
Age-related macular degeneration |
Macular degeneration, age-related, 15 (ARMD15) [MIM:615591] |
C9 |
Macular degeneration, age-related, 3 (ARMD3) [MIM:608895] |
FBLN5 |
Macular degeneration, age-related, 4 (ARMD4) [MIM:610698] |
CFH |
Neuropathy, hereditary, with or without age-related macular degeneration (HNARMD) [MIM:608895] |
FBLN5 |
Aicardi-Goutieres syndrome |
Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181] |
RNASEH2B |
Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952] |
SAMHD1 |
Alagille syndrome |
Alagille syndrome 1 (ALGS1) [MIM:118450] |
JAG1 |
Alazami-Yuan syndrome |
Alazami-Yuan syndrome (ALYUS) [MIM:617126] |
TAF6 |
Alexander disease |
Alexander disease (ALXDRD) [MIM:203450] |
GFAP |
Alpha-methylacetoacetic aciduria |
3-ketothiolase deficiency (3KTD) [MIM:203750] |
ACAT1 |
Alpha-thalassemia mental retardation syndrome, X-linked (ATRX) [MIM:301040] |
Alpha-thalassemia mental retardation syndrome, X-linked (ATRX) [MIM:301040] |
ATRX |
Alzheimer disease |
Alzheimer disease 1 (AD1) [MIM:104300] |
APP |
Alzheimer disease 2 (AD2) [MIM:104310] |
APOE |
Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
MT-ND2, MT-ND1 |
Amelogenesis imperfecta |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
ITGB6 |
Amyloidosis |
Amyloidosis 5 (AMYL5) [MIM:105120] |
GSN |
Amyloidosis 8 (AMYL8) [MIM:105200] |
Amyloidosis 8 (AMYL8) [MIM:105200] |
B2M, APOA1 |
Amyotrophic lateral sclerosis |
Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069] |
TARDBP |
Amyotrophic lateral sclerosis 12 (ALS12) [MIM:613435] |
OPTN |
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia (ALS14) [MIM:613954] |
VCP |
Amyotrophic lateral sclerosis 17 (ALS17) [MIM:614696] |
CHMP2B |
Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808] |
PFN1 |
Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515] |
ERBB4 |
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030] |
FUS |
Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895] |
ANG |
Amyotrophic lateral sclerosis (ALS) [MIM:105400] |
Amyotrophic lateral sclerosis (ALS) [MIM:105400] |
DCTN1 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
HNRNPA1 |
Aniridia |
Aniridia 1 (AN1) [MIM:106210] |
PAX6 |
Antley-Bixler syndrome |
Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410] |
FGFR2 |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
MYLK |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
FGFR2 |
Arrhythmogenic right ventricular dysplasia |
Arrhythmogenic right ventricular dysplasia, familial, 13 (ARVD13) [MIM:615616] |
CTNNA3 |
Asplenia |
Asplenia, isolated congenital (ICAS) [MIM:271400] |
RPSA |
Atrial septal defect |
Atrial fibrillation, familial, 13 (ATFB13) [MIM:615377] |
SCN1B |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
SCN2B |
Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554] |
KCNQ1 |
Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980] |
KCNJ2 |
Auriculocondylar syndrome |
Auriculocondylar syndrome 1 (ARCND1) [MIM:602483] |
GNAI3 |
Autoimmune disease, multisystem, infantile-onset, |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
STAT3 |
Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2) [MIM:617006] |
ZAP70 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
SMARCB1 |
Coffin-Siris syndrome 4 (CSS4) [MIM:614609] |
SMARCA4 |
Autoimmune lymphoproliferative syndrome |
Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859] |
FAS |
Autoimmune lymphoproliferative syndrome 5 (ALPS5) [MIM:616100] |
CTLA4 |
Caspase-8 deficiency (CASP8D) [MIM:607271] |
CASP8 |
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300] |
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300] |
AIRE |
Autoinflammation, antibody deficiency, and immune dysregulation |
Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878] |
PLCG2 |
Baraitser-Winter syndrome |
Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310] |
ACTB |
Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583] |
ACTG1 |
Bardet-Biedl syndrome |
Bardet-Biedl syndrome 1 (BBS1) [MIM:209900] |
BBS1 |
Bardet-Biedl syndrome 4 (BBS4) [MIM:615982] |
BBS4 |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
BBS12 |
Bare lymphocyte syndrome |
Bare lymphocyte syndrome 2 (BLS2) [MIM:209920] |
RFXANK |
Basal cell nevus syndrome |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
NRAS |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
FGFR3 |
Bleeding disorder |
Bleeding disorder, platelet-type 11 (BDPLT11) [MIM:614201] |
GP6 |
Bleeding disorder, platelet-type 15 (BDPLT15) [MIM:615193] |
ACTN1 |
Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800] |
ITGA2B, ITGB3 |
Blepharocheilodontic syndrome |
Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580] |
CDH1 |
Brachydactyly |
Brachydactyly C (BDC) [MIM:113100] |
GDF5 |
Brachydactyly E2 (BDE2) [MIM:613382] |
PTHLH |
Branchiootic syndrome |
Branchiootic syndrome 3 (BOS3) [MIM:608389] |
SIX1 |
Breast cancer |
Breast cancer (BC) [MIM:114480] |
BRCA2, PALB2, CHEK2, BRCA1 |
Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370] |
BRCA1 |
Bronchiectasis |
Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021] |
SCNN1A |
Brugada syndrome |
Brugada syndrome 1 (BRGDA1) [MIM:601144] |
SCN5A |
Camptodactyly tall stature and hearing loss syndrome |
Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM:610474] |
FGFR3 |
Cardiospondylocarpofacial syndrome (CSCF) [MIM:157800] |
MAP3K7 |
Camurati-Engelmann disease |
Camurati-Engelmann disease (CAEND) [MIM:131300] |
TGFB1 |
Candidiasis |
Candidiasis, familial, 6 (CANDF6) [MIM:613956] |
IL17F |
Cardiofaciocutaneous syndrome |
Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150] |
BRAF |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
KRAS |
Cardiomyopathy |
Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200] |
LMNA |
Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158] |
ACTN2 |
Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494] |
TNNT2 |
Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286] |
TNNI3 |
Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642] |
SDHA |
Cardiomyopathy, dilated 1II (CMD1II) [MIM:615184] |
CRYAB |
Cardiomyopathy, dilated 1NN (CMD1NN) [MIM:615916] |
RAF1 |
Cardiomyopathy, dilated 1R (CMD1R) [MIM:613424] |
ACTC1 |
Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426] |
MYH7 |
Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407] |
VCL |
Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878] |
TPM1 |
Cardiomyopathy, dilated 1Z (CMD1Z) [MIM:611879] |
TNNC1 |
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
LMNA |
Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098] |
ACTC1 |
Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243] |
TNNC1 |
Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158] |
ACTN2 |
Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196] |
TPM1 |
Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858] |
PRKAG2 |
Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690] |
TNNI3 |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
TNNI3 |
Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197] |
Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197] |
MYBPC3 |
Carney complex |
Carney complex 1 (CNC1) [MIM:160980] |
PRKAR1A |
Cataract |
Cataract 17, multiple types (CTRCT17) [MIM:611544] |
CRYBB1 |
Cataract 23, multiple types (CTRCT23) [MIM:610425] |
CRYBA4 |
Cataract 30, multiple types (CTRCT30) [MIM:116300] |
VIM |
Cataract 31, multiple types (CTRCT31) [MIM:605387] |
CHMP4B |
Cataract 42 (CTRCT42) [MIM:115900] |
CRYBA2 |
Cerebellar ataxia and hypogonadotropic hypogonadism |
Hypogonadotropic hypogonadism 24 without anosmia (HH24) [MIM:229070] |
FSHB |
Cerebral amyloid angiopathy |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
APP |
Cerebral cavernous malformations |
Cerebral cavernous malformations 2 (CCM2) [MIM:603284] |
CCM2 |
Cerebrocostomandibular syndrome |
Cerebrocostomandibular syndrome (CCMS) [MIM:117650] |
SNRPB |
Cerebrooculofacioskeletal syndrome |
Cerebro-oculo-facio-skeletal syndrome 2 (COFS2) [MIM:610756] |
ERCC2 |
Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758] |
ERCC1 |
Cervical cancer |
Cervical cancer (CERCA) [MIM:603956] |
FGFR3 |
Charcot-Marie-Tooth disease |
Charcot-Marie-Tooth disease 2B (CMT2B) [MIM:600882] |
RAB7A |
Charcot-Marie-Tooth disease 2E (CMT2E) [MIM:607684] |
NEFL |
Charcot-Marie-Tooth disease 2F (CMT2F) [MIM:606595] |
HSPB1 |
Charcot-Marie-Tooth disease 2O (CMT2O) [MIM:614228] |
DYNC1H1 |
Charcot-Marie-Tooth disease 2Y (CMT2Y) [MIM:616687] |
VCP |
Charcot-Marie-Tooth disease, X-linked recessive, 5 (CMTX5) [MIM:311070] |
PRPS1 |
Charcot-Marie-Tooth disease, dominant intermediate G (CMTDIG) [MIM:617882] |
NEFL |
Cherubism |
Cherubism (CRBM) [MIM:118400] |
SH3BP2 |
Childhood cancer retinoblastoma (RB) [MIM:180200] |
Childhood cancer retinoblastoma (RB) [MIM:180200] |
RB1 |
Chronic granulomatous disease |
Granulomatous disease, chronic, cytochrome-b-positive 2, autosomal recessive (CGD2) [MIM:233710] |
NCF2 |
Chronic infantile neurologic cutaneous and articular syndrome |
Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
NLRP3 |
Coagulation factor deficiency |
Factor II deficiency (FA2D) [MIM:613679] |
F2 |
Factor XI deficiency (FA11D) [MIM:612416] |
F11 |
Factor XII deficiency (FA12D) [MIM:234000] |
F12 |
Cockayne syndrome |
Cockayne syndrome A (CSA) [MIM:216400] |
ERCC8 |
Coffin-Lowry syndrome |
Coffin-Lowry syndrome (CLS) [MIM:303600] |
RPS6KA3 |
Coffin-Siris syndrome 10 |
Coffin-Siris syndrome 11 (CSS11) [MIM:618779] |
SMARCD1 |
Coffin-Siris syndrome 8 (CSS8) [MIM:618362] |
Coffin-Siris syndrome 8 (CSS8) [MIM:618362] |
SMARCC2 |
Cohen-Gibson syndrome |
Cohen-Gibson syndrome (COGIS) [MIM:617561] |
EED |
Coloboma, ocular |
Coloboma of optic nerve (COLON) [MIM:120430] |
PAX6 |
Coloboma, ocular, autosomal dominant (COAD) [MIM:120200] |
PAX6 |
Colorectal cancer |
Hereditary non-polyposis colorectal cancer 2 (HNPCC2) [MIM:609310] |
MLH1 |
Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470] |
HRAS, NRAS |
Colorectal cancer (CRC) [MIM:114500] |
Colorectal cancer (CRC) [MIM:114500] |
CTNNB1, MT-CO1, BRAF, MLH1 |
Combined oxidative phosphorylation |
Combined oxidative phosphorylation deficiency 33 (COXPD33) [MIM:617713] |
C1QBP |
Combined oxidative phosphorylation deficiency |
Combined oxidative phosphorylation deficiency 19 (COXPD19) [MIM:615595] |
LYRM4 |
Complement component deficiency |
Complement component 7 deficiency (C7D) [MIM:610102] |
C7 |
Complement factors deficiency |
Complement factor I deficiency (CFI deficiency) [MIM:610984] |
CFI |
Cone-rod dystrophy |
Cone-rod dystrophy 2 (CORD2) [MIM:120970] |
CRX |
Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940] |
PCYT1A |
Congenital bilateral absence of the vas deferens |
Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
CFTR |
Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
RET |
Congenital clubfoot |
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly (CCF) [MIM:119800] |
PITX1 |
Congenital heart defects |
Congenital heart defects and skeletal malformations syndrome (CHDSKM) [MIM:617602] |
ABL1 |
Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159] |
CHD4 |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
CDC42 |
Congenital heart defects and ectodermal dysplasia |
Congenital heart defects and ectodermal dysplasia (CHDED) [MIM:617364] |
PRKD1 |
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder |
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360] |
CDK13 |
Congenital short bowel syndrome |
Congenital short bowel syndrome (CSBS) [MIM:615237] |
CLMP |
Cornelia de Lange syndrome |
Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470] |
NIPBL |
Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590] |
SMC1A |
Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701] |
RAD21 |
Cortical dysplasia complex with other brain malformations |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
TUBB3 |
Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771] |
TUBB |
Cowden disease |
Cowden syndrome 1 (CWS1) [MIM:158350] |
PTEN |
Cowden syndrome 6 (CWS6) [MIM:615109] |
AKT1 |
Craniosynostosis |
Craniosynostosis 3 (CRS3) [MIM:615314] |
TCF12 |
Craniosynostosis 7 (CRS7) [MIM:617439] |
SMAD6 |
Trigonocephaly 1 (TRIGNO1) [MIM:190440] |
FGFR1 |
Crohn disease |
Inflammatory bowel disease 1 (IBD1) [MIM:266600] |
NOD2 |
Crouzon syndrome |
Crouzon syndrome (CS) [MIM:123500] |
FGFR2 |
Crouzon syndrome with acanthosis nigricans (CAN) [MIM:612247] |
FGFR3 |
Cutis laxa |
Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100] |
FBLN5 |
Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402] |
ATP6V1E1 |
Cutis laxa, autosomal recessive, 2D (ARCL2D) [MIM:617403] |
ATP6V1A |
Cyanosis |
Cyanosis transient neonatal (TNCY) [MIM:613977] |
HBG2 |
Cyclic haematopoiesis (CH) [MIM:162800] |
Cyclic haematopoiesis (CH) [MIM:162800] |
ELANE |
Cystic fibrosis (CF) [MIM:219700] |
Cystic fibrosis (CF) [MIM:219700] |
CFTR |
Deafness |
Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717] |
ACTG1 |
Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101] |
KCNQ4 |
Deafness, autosomal dominant, 64 (DFNA64) [MIM:614152] |
DIABLO |
Deafness, autosomal dominant, 70 (DFNA70) [MIM:616968] |
MCM2 |
Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565] |
ESRRB |
Deafness, autosomal recessive, 89 (DFNB89) [MIM:613916] |
KARS1 |
Dementia |
Dementia, Lewy body (DLB) [MIM:127750] |
SNCA |
Frontotemporal dementia (FTD) [MIM:600274] |
MAPT |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437] |
SQSTM1 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439] |
TBK1 |
Denys-Drash syndrome |
Denys-Drash syndrome (DDS) [MIM:194080] |
WT1 |
Diabetes mellitus |
Diabetes mellitus, insulin-dependent, 2 (IDDM2) [MIM:125852] |
INS |
Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853] |
INSR |
Diabetes mellitus, permanent neonatal 4 (PNDM4) [MIM:618858] |
INS |
Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
INSR |
Maturity-onset diabetes of the young 13 (MODY13) [MIM:616329] |
KCNJ11 |
Du Pan syndrome |
Du Pan syndrome (DUPANS) [MIM:228900] |
GDF5 |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
FGG, FGA, FGB |
Dystonia |
Dystonia, juvenile-onset (DJO) [MIM:607371] |
ACTB |
Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540] |
LMNB2 |
Ectodermal dysplasia |
Ectodermal dysplasia 7, hair/nail type (ECTD7) [MIM:614929] |
KRT74 |
Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291] |
IKBKG |
Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies (EDFAOB) [MIM:618727] |
RHOA |
Ectrodactyly-ectodermal dysplasia |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
TP63 |
Ehlers-Danlos syndrome |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
COL3A1 |
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV) [MIM:618343] |
COL3A1 |
Elliptocytosis |
Elliptocytosis 2 (EL2) [MIM:130600] |
SPTA1 |
Elliptocytosis 3 (EL3) [MIM:617948] |
SPTB |
Emery-Dreifuss muscular dystrophy |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
LMNA |
Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516] |
LMNA |
Encephalocraniocutaneous lipomatosis |
Encephalocraniocutaneous lipomatosis (ECCL) [MIM:613001] |
FGFR1 |
Encephalopathy, acute, infection-induced (herpes-specific) |
Encephalopathy, acute, infection-induced, Herpes-specific, 7 (IIAE7) [MIM:616532] |
IRF3 |
Encephalopathy, acute, infection-induced, herpes-specific, 8 (IIAE8) [MIM:617900] |
TBK1 |
Enhanced S cone syndrome |
Enhanced S cone syndrome (ESCS) [MIM:268100] |
NR2E3 |
Epidermolysis bullosa |
Epidermolysis bullosa letalis, with pyloric atresia (EB-PA) [MIM:226730] |
ITGB4 |
Epidermolysis bullosa simplex, Dowling-Meara type (DM-EBS) [MIM:131760] |
KRT14, KRT5 |
Epidermolysis bullosa simplex, Koebner type (K-EBS) [MIM:131900] |
KRT14, KRT5 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
KRT14 |
Epidermolysis bullosa simplex, autosomal recessive 1 (EBSB1) [MIM:601001] |
KRT5 |
Epidermolytic hyperkeratosis |
Epidermolytic hyperkeratosis (EHK) [MIM:113800] |
KRT1, KRT10 |
Epilepsy |
Epilepsy, childhood absence 2 (ECA2) [MIM:607681] |
GABRG2 |
Epilepsy, childhood absence 5 (ECA5) [MIM:612269] |
GABRB3 |
Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364] |
DEPDC5 |
Epilepsy, focal, with speech disorder and with or without mental retardation (FESD) [MIM:245570] |
GRIN2A |
Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136] |
GABRA1 |
Generalized epilepsy with febrile seizures plus 1 (GEFS+1) [MIM:604233] |
SCN1B |
Generalized epilepsy with febrile seizures plus 2 (GEFS+2) [MIM:604403] |
SCN1A |
Generalized epilepsy with febrile seizures plus 3 (GEFS+3) [MIM:607681] |
GABRG2 |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
STX1B |
Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
SCN1A |
Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136] |
GABRA1 |
Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3) [MIM:609446] |
KCNMA1 |
Epileptic encephalopathy |
Epileptic encephalopathy, early infantile, 11 (EIEE11) [MIM:613721] |
SCN2A |
Epileptic encephalopathy, early infantile, 17 (EIEE17) [MIM:615473] |
GNAO1 |
Epileptic encephalopathy, early infantile, 2 (EIEE2) [MIM:300672] |
CDKL5 |
Epileptic encephalopathy, early infantile, 31 (EIEE31) [MIM:616346] |
DNM1 |
Epileptic encephalopathy, early infantile, 33 (EIEE33) [MIM:616409] |
EEF1A2 |
Epileptic encephalopathy, early infantile, 4 (EIEE4) [MIM:612164] |
STXBP1 |
Epileptic encephalopathy, early infantile, 44 (EIEE44) [MIM:617132] |
UBA5 |
Epileptic encephalopathy, early infantile, 52 (EIEE52) [MIM:617350] |
SCN1B |
Epileptic encephalopathy, early infantile, 56 (EIEE56) [MIM:617665] |
YWHAG |
Epileptic encephalopathy, early infantile, 59 (EIEE59) [MIM:617904] |
GABBR2 |
Episodic pain syndrome |
Episodic pain syndrome, familial, 1 (FEPS1) [MIM:615040] |
TRPA1 |
Erythermalgia |
Primary erythermalgia (PERYTHM) [MIM:133020] |
SCN9A |
Erythrocytosis |
Erythrocytosis, familial, 2 (ECYT2) [MIM:263400] |
VHL |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
EPAS1 |
Esophageal cancer |
Esophageal cancer (ESCR) [MIM:133239] |
TGFBR2 |
Estrogen resistance |
Estrogen resistance (ESTRR) [MIM:615363] |
ESR1 |
Facial paresis |
Facial paresis, hereditary congenital, 3 (HCFP3) [MIM:614744] |
HOXB1 |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
HRAS |
Factor X deficiency (FA10D) [MIM:227600] |
Factor X deficiency (FA10D) [MIM:227600] |
F10 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
APC |
Familial advanced sleep-phase syndrome |
Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224] |
CSNK1D |
Familial cold autoinflammatory syndrome |
Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100] |
NLRP3 |
Familial hyperproinsulinemia |
Hyperproinsulinemia (HPRI) [MIM:616214] |
INS |
Fanconi anemia |
Fanconi anemia complementation group D1 (FANCD1) [MIM:605724] |
BRCA2 |
Fanconi anemia complementation group I (FANCI) [MIM:609053] |
FANCI |
Fanconi anemia complementation group Q (FANCQ) [MIM:615272] |
ERCC4 |
Fanconi anemia complementation group T (FANCT) [MIM:616435] |
UBE2T |
Fanconi anemia, complementation group R (FANCR) [MIM:617244] |
RAD51 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
BRCA1 |
Feingold syndrome |
Feingold syndrome 1 (FGLDS1) [MIM:164280] |
MYCN |
Fibrodysplasia ossificans progressiva |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
ACVR1 |
Fibrosis of extraocular muscles |
Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700] |
KIF21A |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
TUBB3 |
Focal facial dermal dysplasia |
Focal facial dermal dysplasia 3, Setleis type (FFDD3) [MIM:227260] |
TWIST2 |
Focal segmental glomerulosclerosis |
Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965] |
TRPC6 |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
ACTN4 |
Fragile X syndrome |
Fragile X syndrome (FXS) [MIM:300624] |
FMR1 |
Frontometaphyseal dysplasia |
Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137] |
MAP3K7 |
Gabriele-de Vries syndrome |
Gabriele-de Vries syndrome (GADEVS) [MIM:617557] |
YY1 |
Galactosialidosis |
Galactosialidosis (GSL) [MIM:256540] |
CTSA |
Galloway-Mowat syndrome |
Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006] |
LAGE3 |
Gastric cancer |
Gastric cancer (GASC) [MIM:613659] |
KRAS |
Hereditary diffuse gastric cancer (HDGC) [MIM:137215] |
CDH1 |
Gastrointestinal stromal tumor |
Gastrointestinal stromal tumor (GIST) [MIM:606764] |
PDGFRA |
Germ cell tumor |
Testicular germ cell tumor (TGCT) [MIM:273300] |
FGFR3, STK11 |
Glanzmann thrombasthenia |
Glanzmann thrombasthenia (GT) [MIM:273800] |
ITGA2B, ITGB3 |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
OPTN |
Glioma (GLM) [MIM:137800] |
Glioma (GLM) [MIM:137800] |
H3C1, H3-3A |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
NR3C1 |
Glutaric aciduria |
Glutaric aciduria 2B (GA2B) [MIM:231680] |
ETFB |
Glycogen storage disease of heart |
Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740] |
PRKAG2 |
Growth hormone deficiency |
Growth hormone deficiency, isolated, 2 (IGHD2) [MIM:173100] |
GH1 |
Growth hormone insensitivity |
Growth hormone insensitivity with immunodeficiency (GHII) [MIM:245590] |
STAT5B |
Growth hormone insensitivity, partial (GHIP) [MIM:604271] |
GHR |
Growth retardation |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
CSNK2A1 |
Hartsfield syndrome |
Hartsfield syndrome (HRTFDS) [MIM:615465] |
FGFR1 |
Hemangioma capillary infantile |
Hemangioma, capillary infantile (HCI) [MIM:602089] |
FLT4 |
Hemolytic uremic syndrome |
Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400] |
CFH |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
C3 |
Hemorrhagic destruction of the brain with subependymal calcification and cataracts |
Hemorrhagic destruction of the brain with subependymal calcification and cataracts (HDBSCC) [MIM:613730] |
JAM3 |
Hemorrhagic telangiectasia |
Telangiectasia, hereditary hemorrhagic, 5 (HHT5) [MIM:615506] |
GDF2 |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
MET |
Hirschsprung disease |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
RET |
Hirschsprung disease 3 (HSCR3) [MIM:613711] |
GDNF |
Holt-Oram syndrome |
Holt-Oram syndrome (HOS) [MIM:142900] |
TBX5 |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
LMNA |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060] |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060] |
STAT3 |
Hypercholanemia |
Familial hypercholanemia (FHCA) [MIM:607748] |
TJP2 |
Hypercholesterolemia |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
PCSK9 |
Hyperinsulinemic hypoglycemia |
Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968] |
INSR |
Hyperoxaluria |
Hyperoxaluria primary 1 (HP1) [MIM:259900] |
AGXT |
Hyperparathyroidism |
Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188] |
TRPV6 |
Hyperphenylalaninemia |
Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910] |
GCH1 |
Hyperthyroxinemia, dystransthyretinemic |
Hyperthyroxinemia, dystransthyretinemic (DTTRH) [MIM:145680] |
TTR |
Hypochondroplasia |
Hypochondroplasia (HCH) [MIM:146000] |
FGFR3 |
Hypogonadotropic hypogonadism |
Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] |
FGFR1 |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281] |
DARS1 |
Hypophosphataemic rickets |
Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100] |
FGF23 |
Hypothyroidism |
Hypothyroidism, congenital, non-goitrous, 5 (CHNG5) [MIM:225250] |
NKX2-5 |
Hypothyroidism, congenital, non-goitrous, 6 (CHNG6) [MIM:614450] |
THRA |
Hypotonia, ataxia, and delayed development syndrome |
Hypotonia, ataxia, and delayed development syndrome (HADDS) [MIM:617330] |
EBF3 |
Ichthyosis |
Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
KRT1, KRT10 |
Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400] |
ST14 |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
SUZ12 |
Immunodeficiency |
Immunodeficiency 10 (IMD10) [MIM:612783] |
STIM1 |
Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638] |
CARD11 |
Immunodeficiency 16 (IMD16) [MIM:615593] |
TNFRSF4 |
Immunodeficiency 20 (IMD20) [MIM:615707] |
FCGR3A |
Immunodeficiency 27A (IMD27A) [MIM:209950] |
IFNGR1 |
Immunodeficiency 28 (IMD28) [MIM:614889] |
IFNGR2 |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
STAT1 |
Immunodeficiency 33 (IMD33) [MIM:300636] |
IKBKG |
Immunodeficiency 67 (IMD67) [MIM:607676] |
IRAK4 |
Immunodeficiency 68 (IMD68) [MIM:612260] |
MYD88 |
Immunodeficiency 9 (IMD9) [MIM:612782] |
ORAI1 |
Immunodeficiency-centromeric instability-facial anomalies syndrome |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860] |
DNMT3B |
Inclusion body myopathy |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 (IBMPFD2) [MIM:615422] |
HNRNPA2B1 |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 (IBMPFD3) [MIM:615424] |
HNRNPA1 |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320] |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320] |
VCP |
Incontinentia pigmenti |
Incontinentia pigmenti (IP) [MIM:308300] |
IKBKG |
Infections recurrent associated with encephalopathy hepatic dysfunction and cardiovascular malformations |
Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759] |
FADD |
Inflammatory bowel disease |
Inflammatory bowel disease 28 (IBD28) [MIM:613148] |
IL10RA |
Inflammatory bowel disease, immunodeficiency, and encephalopathy (IBDIMDE) [MIM:618213] |
TGFB1 |
Insensitivity to pain |
Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
NTRK1 |
Indifference to pain, congenital, autosomal recessive (CIP) [MIM:243000] |
SCN9A |
Insulin-like growth factor 1 resistance |
Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
IGF1R |
Intellectual developmental disorder with dysmorphic facies and ptosis |
Intellectual developmental disorder 59 (MRD59) [MIM:618522] |
CAMK2G |
Intellectual developmental disorder with hypertelorism and distinctive facies (IDDHDF) [MIM:618147] |
CCNK |
Intellectual developmental disorder with macrocephaly, seizures, and speech delay (IDDMSSD) [MIM:618158] |
PAK1 |
Intellectual developmental disorder with impaired language and dysmorphic facies |
Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653] |
DDX6 |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
TRIO |
Interstitial lung and liver disease |
Rajab interstitial lung disease with brain calcifications (RILDBC) [MIM:613658] |
FARSB |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
FGFR2, FGFR1 |
Jervell and Lange-Nielsen syndrome |
Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400] |
KCNQ1 |
Juvenile polyposis |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
BMPR1A, SMAD4 |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
SMAD4 |
Kabuki syndrome 1 (KABUK1) [MIM:147920] |
Kabuki syndrome 1 (KABUK1) [MIM:147920] |
KMT2D |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
FGFR3, NRAS |
Keratoendothelitis fugax hereditaria |
Keratoendothelitis fugax hereditaria (KEFH) [MIM:148200] |
NLRP3 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
FGFR3 |
Lacrimo-auriculo-dento-digital syndrome |
Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
FGFR2, FGFR3 |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
MT-ND5, MT-CO3, MT-ND6, MT-ND4L, MT-ND2 |
Leber optic neuropathy |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
MT-ND6 |
Left ventricular non-compaction |
Left ventricular non-compaction 9 (LVNC9) [MIM:611878] |
TPM1 |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
MYH7 |
Leigh syndrome (LS) [MIM:256000] |
Leigh syndrome (LS) [MIM:256000] |
MT-ND6, MT-ND3 |
Leopard syndrome |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
PTPN11 |
LEOPARD syndrome 2 (LPRD2) [MIM:611554] |
RAF1 |
Leprechaunism |
Leprechaunism (LEPRCH) [MIM:246200] |
INSR |
Lethal congenital contracture syndrome |
Lethal congenital contracture syndrome 1 (LCCS1) [MIM:253310] |
GLE1 |
Leukemia |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
PTPN11, NRAS, KRAS |
Leukemia, acute myelogenous (AML) [MIM:601626] |
Leukemia, acute myelogenous (AML) [MIM:601626] |
DNMT3A |
Leukocyte adhesion deficiency |
Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920] |
ITGB2 |
Leukodystrophy hypomyelinating |
Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494] |
POLR1C |
Leukodystrophy, hypomyelinating, 14 (HLD14) [MIM:617899] |
UFM1 |
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
POLR3A |
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381] |
POLR3B |
Leukodystrophy with vanishing white matter |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
EIF2B3, EIF2B5, EIF2B4, EIF2B1, EIF2B2 |
Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951] |
Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951] |
EPRS1 |
Li-Fraumeni syndrome |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
TP53 |
Liang-Wang syndrome |
Liang-Wang syndrome (LIWAS) [MIM:618729] |
KCNMA1 |
Limb-girdle muscular dystrophy |
Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
LMNA |
Lipodystrophy |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
LMNA |
Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367] |
PPARG |
Partial acquired lipodystrophy (APLD) [MIM:608709] |
LMNB2 |
Lissencephaly |
Lissencephaly 3 (LIS3) [MIM:611603] |
TUBA1A |
Lissencephaly with microcephaly |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
KATNB1 |
Loeys-Dietz syndrome |
Loeys-Dietz syndrome 1 (LDS1) [MIM:609192] |
TGFBR1 |
Loeys-Dietz syndrome 2 (LDS2) [MIM:610168] |
TGFBR2 |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
SMAD3 |
Long QT syndrome |
Long QT syndrome 14 (LQT14) [MIM:616247] |
CALM1 |
Long QT syndrome 15 (LQT15) [MIM:616249] |
CALM2 |
Long QT syndrome 16 (LQT16) [MIM:618782] |
CALM3 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
KCNJ2 |
Lung cancer (LNCR) [MIM:211980] |
Lung cancer (LNCR) [MIM:211980] |
BRAF |
Lymphoma |
Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240] |
SH2D1A |
MASP2 deficiency |
MASP2 deficiency (MASPD) [MIM:613791] |
MASP2 |
MEHMO syndrome (MEHMO) [MIM:300148] |
MEHMO syndrome (MEHMO) [MIM:300148] |
EIF2S3 |
Macular dystrophy |
Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970] |
CTNNA1 |
Mandibuloacral dysplasia |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
LMNA |
Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612] |
ZMPSTE24 |
Mandibulofacial dysostosis |
Mandibulofacial dysostosis with microcephaly (MFDM) [MIM:610536] |
EFTUD2 |
Mastocytosis, cutaneous |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
KIT |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
KIT |
Maturity-onset diabetes of the young |
Maturity-onset diabetes of the young 1 (MODY1) [MIM:125850] |
HNF4A |
Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370] |
INS |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
GNAS |
Meacham syndrome |
Meacham syndrome (MEACHS) [MIM:608978] |
WT1 |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
RET |
Medulloblastoma |
Medulloblastoma (MDB) [MIM:155255] |
APC, CTNNB1 |
Meesmann corneal dystrophy |
Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767] |
KRT3 |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937] |
AKT3 |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
PIK3R2 |
Meier-Gorlin syndrome |
Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690] |
ORC1 |
Meier-Gorlin syndrome 2 (MGORS2) [MIM:613800] |
ORC4 |
Meier-Gorlin syndrome 8 (MGORS8) [MIM:617564] |
MCM5 |
Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063] |
Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063] |
CDC45 |
Melanoma |
Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848] |
POT1 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
CDK4 |
Melanosis, neurocutaneous |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
NRAS |
Mental retardation |
Mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH) [MIM:300749] |
CASK |
Mental retardation with language impairment and autistic features (MRLIAF) [MIM:613670] |
FOXP1 |
Mental retardation, X-linked, syndromic, 33 (MRXS33) [MIM:300966] |
TAF1 |
Mental retardation, X-linked, syndromic, Turner type (MRXST) [MIM:309590] |
HUWE1 |
Mental retardation, autosomal dominant 13 (MRD13) [MIM:614563] |
DYNC1H1 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
PPP2R1A |
Mental retardation, autosomal dominant 38 (MRD38) [MIM:616393] |
EEF1A2 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
GNB1 |
Mental retardation, autosomal dominant 47 (MRD47) [MIM:617635] |
STAG1 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
RAC1 |
Mental retardation, autosomal dominant 54 (MRD54) [MIM:617799] |
CAMK2B |
Mental retardation, autosomal recessive 34, with variant lissencephaly (MRT34) [MIM:614499] |
CRADD |
Mental retardation, autosomal recessive 60 (MRT60) [MIM:617432] |
TAF13 |
Mental retardation, autosomal recessive 63 (MRT63) [MIM:618095] |
CAMK2A |
Mental retardation, autosomal recessive 64 (MRT64) [MIM:618103] |
LINGO1 |
Mental retardation, autosomal dominant 53 (MRD53) [MIM:617798] |
Mental retardation, autosomal dominant 53 (MRD53) [MIM:617798] |
CAMK2A |
Microcephaly |
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR) [MIM:152950] |
KIF11 |
Neurodevelopmental disorder with microcephaly and structural brain anomalies (NEDMIBA) [MIM:618492] |
DYNC1I2 |
Microcephaly-capillary malformation syndrome |
Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261] |
STAMBP |
Microphthalmia |
Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524] |
RARB |
Mirror movements 1 (MRMV1) [MIM:157600] |
Mirror movements 1 (MRMV1) [MIM:157600] |
DCC |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
MT-CO1, MT-CO2, COX6B1 |
Mitochondrial complex deficiency |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
MT-ND3 |
Mitochondrial complex I deficiency, nuclear type 1 (MC1DN1) [MIM:252010] |
NDUFS4 |
Mitochondrial complex I deficiency, nuclear type 12 (MC1DN12) [MIM:301020] |
NDUFA1 |
Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222] |
NDUFS8 |
Mitochondrial complex I deficiency, nuclear type 24 (MC1DN24) [MIM:618245] |
NDUFB9 |
Mitochondrial complex I deficiency, nuclear type 25 (MC1DN25) [MIM:618246] |
NDUFB3 |
Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247] |
NDUFA9 |
Mitochondrial complex I deficiency, nuclear type 28 (MC1DN28) [MIM:618249] |
NDUFA13 |
Mitochondrial complex I deficiency, nuclear type 30 (MC1DN30) [MIM:301021] |
NDUFB11 |
Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252] |
NDUFB8 |
Mitochondrial complex I deficiency, nuclear type 33 (MC1DN33) [MIM:618253] |
NDUFA6 |
Mitochondrial complex I deficiency, nuclear type 4 (MC1DN4) [MIM:618225] |
NDUFV1 |
Mitochondrial complex I deficiency, nuclear type 5 (MC1DN5) [MIM:618226] |
NDUFS1 |
Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228] |
NDUFS2 |
Mitochondrial complex I deficiency, nuclear type 8 (MC1DN8) [MIM:618230] |
NDUFS3 |
Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232] |
NDUFS6 |
Mitochondrial complex II deficiency (MT-C2D) [MIM:252011] |
SDHA |
Mitochondrial complex III deficiency, nuclear 5 (MC3DN5) [MIM:615160] |
UQCRC2 |
Mitochondrial complex III deficiency, nuclear 6 (MC3DN6) [MIM:615453] |
CYC1 |
Mitochondrial complex V deficiency, nuclear type 4 (MC5DN4) [MIM:615228] |
ATP5F1A |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
MT-ND5, MT-ND6, MT-ND1 |
Mohr-Tranebjaerg syndrome |
Mohr-Tranebjaerg syndrome (MTS) [MIM:304700] |
TIMM8A |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
KRT81, KRT86, KRT83 |
Muenke syndrome |
Muenke syndrome (MNKS) [MIM:602849] |
FGFR3 |
Multicentric osteolysis, nodulosis, and arthropathy |
Multicentric osteolysis, nodulosis, and arthropathy (MONA) [MIM:259600] |
MMP2 |
Multiple neoplasia |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
RET |
Multiple neoplasia 2B (MEN2B) [MIM:162300] |
RET |
Multiple self-healing squamous epithelioma |
Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
TGFBR1 |
Multiple synostoses syndrome |
Multiple synostoses syndrome 1 (SYNS1) [MIM:186500] |
NOG |
Myasthenic syndrome |
Myasthenic syndrome, congenital, 18 (CMS18) [MIM:616330] |
SNAP25 |
Myeloperoxidase deficiency |
Myeloperoxidase deficiency (MPOD) [MIM:254600] |
MPO |
Myopathy |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
HRAS |
Myopathy, centronuclear, 2 (CNM2) [MIM:255200] |
BIN1 |
Myopathy, distal, 1 (MPD1) [MIM:160500] |
MYH7 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
DES |
Myopathy, myofibrillar, 2 (MFM2) [MIM:608810] |
CRYAB |
Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358] |
MYH7 |
Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883] |
ORAI1 |
N-terminal acetyltransferase deficiency |
N-terminal acetyltransferase deficiency (NATD) [MIM:300855] |
NAA10 |
Narcolepsy |
Narcolepsy 1 (NRCLP1) [MIM:161400] |
HCRT |
Nemaline myopathy |
Cap myopathy 1 (CAPM1) [MIM:609284] |
TPM3 |
Nemaline myopathy 1 (NEM1) [MIM:609284] |
TPM3 |
Nephrotic syndrome |
Nephrotic syndrome 11 (NPHS11) [MIM:616730] |
NUP107 |
Nephrotic syndrome 12 (NPHS12) [MIM:616892] |
NUP93 |
Nephrotic syndrome 16 (NPHS16) [MIM:617783] |
KANK2 |
Nestor-Guillermo progeria syndrome |
Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008] |
BANF1 |
Neuroblastoma |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
ALK |
Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia |
Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718] |
NTNG2 |
Neurodevelopmental disorder with brain, liver, and lung abnormalities |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
PPP2CA |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577] |
RAC3 |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760] |
VAMP2 |
Neurodevelopmental disorder with involuntary movements |
Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493] |
GNAO1 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
GRIN1 |
Neurofibromatosis |
Neurofibromatosis 1 (NF1) [MIM:162200] |
NF1 |
Neurofibromatosis 2 (NF2) [MIM:101000] |
NF2 |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
NF1 |
Neuronopathy |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
HSPB8 |
Neuropathy |
Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400] |
SPTLC1 |
Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640] |
SPTLC2 |
Neuropathy, hereditary sensory and autonomic, 5 (HSAN5) [MIM:608654] |
NGF |
Neutropenia |
Dominant nonimmune chronic idiopathic neutropenia of adults (NI-CINA) [MIM:607847] |
GFI1 |
Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752] |
SRP54 |
Neutropenia, severe congenital, X-linked (XLN) [MIM:300299] |
WAS |
Neutrophil immunodeficiency syndrome |
Immunodeficiency, common variable, 13 (CVID13) [MIM:616873] |
IKZF1 |
Neutrophil immunodeficiency syndrome (NEUID) [MIM:608203] |
RAC2 |
Niemann-Pick disease |
Niemann-Pick disease C1 (NPC1) [MIM:257220] |
NPC1 |
Non-Hodgkin lymphoma |
Familial non-Hodgkin lymphoma (NHL) [MIM:605027] |
CASP10, BRAF |
Noonan syndrome |
Noonan syndrome 1 (NS1) [MIM:163950] |
PTPN11 |
Noonan syndrome 12 (NS12) [MIM:618624] |
RRAS2 |
Noonan syndrome 3 (NS3) [MIM:609942] |
KRAS |
Noonan syndrome 4 (NS4) [MIM:610733] |
SOS1 |
Noonan syndrome 5 (NS5) [MIM:611553] |
RAF1 |
Noonan syndrome 6 (NS6) [MIM:613224] |
NRAS |
Noonan syndrome 7 (NS7) [MIM:613706] |
BRAF |
Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506] |
PPP1CB |
Noonan-like syndrome |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
CBL |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
NTRK2 |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
KRAS |
Ophthalmoplegia, external, with rib and vertebral anomalies |
Ophthalmoplegia, external, with rib and vertebral anomalies (EORVA) [MIM:618155] |
MYF5 |
Orofacial cleft |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
KDM1A |
Osseous heteroplasia |
Progressive osseous heteroplasia (POH) [MIM:166350] |
GNAS |
Osteogenesis imperfecta |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
COL1A1 |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
SPARC |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
COL1A2, COL1A1 |
Osteogenesis imperfecta 3 (OI3) [MIM:259420] |
COL1A2, COL1A1 |
Osteogenesis imperfecta 4 (OI4) [MIM:166220] |
COL1A1 |
Osteoglophonic dysplasia |
Osteoglophonic dysplasia (OGD) [MIM:166250] |
FGFR1 |
Osteopetrosis autosomal |
Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301] |
TNFRSF11A |
Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600] |
Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600] |
CLCN7 |
Otopalatodigital syndrome |
Otopalatodigital syndrome 2 (OPD2) [MIM:304120] |
FLNA |
Ovarian cancer |
Ovarian cancer (OC) [MIM:167000] |
CTNNB1, BRCA1 |
Ovarian dysgenesis |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
ESR2 |
PCWH |
Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
SOX10 |
Pachyonychia congenita |
Pachyonychia congenita 1 (PC1) [MIM:167200] |
KRT16 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
KRT6A |
Pachyonychia congenita 4 (PC4) [MIM:615728] |
KRT6B |
Paget disease of bone |
Paget disease of bone 3 (PDB3) [MIM:167250] |
SQSTM1 |
Palmoplantar keratoderma |
Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350] |
GJB2 |
Palmoplantar keratoderma, non-epidermolytic, focal or diffuse (PPKNEFD) [MIM:615735] |
KRT6C |
Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760] |
KRT25 |
Pancreatic cancer |
Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719] |
CDKN2A |
Parietal foramina |
Parietal foramina 1 (PFM1) [MIM:168500] |
MSX2 |
Parkinson disease |
Parkinson disease (PARK) [MIM:168600] |
PRKN |
Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601] |
SNCA |
Parkinson disease 6 (PARK6) [MIM:605909] |
PINK1 |
Parkinson disease 8 (PARK8) [MIM:607060] |
LRRK2 |
Paroxysmal extreme pain disorder |
Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
SCN9A |
Periodic fever, familial, autosomal dominant (FPF) [MIM:142680] |
Periodic fever, familial, autosomal dominant (FPF) [MIM:142680] |
TNFRSF1A |
Periventricular heterotopia |
Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201] |
NEDD4L |
Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185] |
Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185] |
ARF1 |
Peroxisome biogenesis disorder |
Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370] |
PEX5 |
Perry syndrome |
Perry syndrome (PERRYS) [MIM:168605] |
DCTN1 |
Peutz-Jeghers syndrome |
Peutz-Jeghers syndrome (PJS) [MIM:175200] |
STK11 |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
FGFR2, FGFR1 |
Pheochromocytoma (PCC) [MIM:171300] |
Pheochromocytoma (PCC) [MIM:171300] |
RET, VHL |
Phosphoribosylpyrophosphate synthetase superactivity |
Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
PRPS1 |
Pick disease of the brain (PIDB) [MIM:172700] |
Pick disease of the brain (PIDB) [MIM:172700] |
MAPT |
Piebaldism |
Piebald trait (PBT) [MIM:172800] |
KIT |
Pigmented adrenocortical disease |
Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830] |
PRKACA |
Pilomatrixoma |
Pilomatrixoma (PTR) [MIM:132600] |
CTNNB1 |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
TCF4 |
Pituitary hormone deficiency |
Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700] |
LHX4 |
Plasminogen deficiency |
Plasminogen deficiency (PLGD) [MIM:217090] |
PLG |
Pneumothorax |
Primary spontaneous pneumothorax (PSP) [MIM:173600] |
FLCN |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
CSNK2B |
Polycystic kidney disease |
Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095] |
PKD2 |
Pontocerebellar hypoplasia |
Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678] |
EXOSC3 |
Pontocerebellar hypoplasia 1C (PCH1C) [MIM:616081] |
EXOSC8 |
Pontocerebellar hypoplasia 1D (PCH1D) [MIM:618065] |
EXOSC9 |
Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809] |
AMPD2 |
Premature chromatid separation trait |
Premature chromatid separation trait (PCS) [MIM:176430] |
BUB1B |
Premature ovarian failure |
Premature ovarian failure 7 (POF7) [MIM:612964] |
NR5A1 |
Progressive external ophthalmoplegia |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131] |
POLG2 |
Properdin deficiency |
Properdin deficiency (PFD) [MIM:312060] |
CFP |
Propionic acidemia |
Propionic acidemia type I (PA-1) [MIM:606054] |
PCCA |
Propionic acidemia type II (PA-2) [MIM:606054] |
PCCB |
Prostate cancer |
Prostate cancer (PC) [MIM:176807] |
CHEK2, EPHB2 |
Pseudohypoaldosteronism |
Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735] |
NR3C2 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
WNK4 |
Pseudohypoparathyroidism |
Albright hereditary osteodystrophy (AHO) [MIM:103580] |
GNAS |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
GNAS |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
GNAS |
Psychomotor retardation, epilepsy, and craniofacial dysmorphism |
Psychomotor retardation, epilepsy, and craniofacial dysmorphism (PMRED) [MIM:614501] |
SNIP1 |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
BMPR2 |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
SPTA1 |
RAS-associated autoimmune leukoproliferative disorder |
RAS-associated autoimmune leukoproliferative disorder (RALD) [MIM:614470] |
NRAS |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
INSR |
Radioulnar synostosis with amegakaryocytic thrombocytopenia |
Thrombocytopenia 6 (THC6) [MIM:616937] |
SRC |
Rapp-Hodgkin syndrome |
Rapp-Hodgkin syndrome (RHS) [MIM:129400] |
TP63 |
Renal cell carcinoma |
Renal cell carcinoma (RCC) [MIM:144700] |
VHL |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
MET |
Retinitis pigmentosa |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
PRPF8 |
Retinitis pigmentosa 18 (RP18) [MIM:601414] |
PRPF3 |
Retinitis pigmentosa 60 (RP60) [MIM:613983] |
PRPF6 |
Retinitis pigmentosa 62 (RP62) [MIM:614181] |
MAK |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
ZNF408 |
Retinitis pigmentosa 74 (RP74) [MIM:616562] |
BBS2 |
Short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF) [MIM:617763] |
EXOSC2 |
Retinitis pigmentosa (RP) [MIM:268000] |
Retinitis pigmentosa (RP) [MIM:268000] |
CRX |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
SNRNP200 |
Richieri-Costa-Pereira syndrome |
Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305] |
EIF4A3 |
Rickets |
Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440] |
VDR |
Ring dermoid of cornea |
Ring dermoid of cornea (RDC) [MIM:180550] |
PITX2 |
Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700] |
Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700] |
WNT5A |
Rubinstein-Taybi syndrome |
Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849] |
CREBBP |
SHORT syndrome |
SHORT syndrome (SHORTS) [MIM:269880] |
PIK3R1 |
Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610] |
TUBB |
Skin creases, congenital symmetric circumferential, 2 (CSCSC2) [MIM:616734] |
MAPRE2 |
STING-associated vasculopathy |
STING-associated vasculopathy, infantile-onset (SAVI) [MIM:615934] |
STING1 |
Saethre-Chotzen syndrome |
Saethre-Chotzen syndrome (SCS) [MIM:101400] |
TWIST1 |
Scaphocephaly syndrome |
Familial scaphocephaly syndrome (FSPC) [MIM:609579] |
FGFR2 |
Schimmelpenning-Feuerstein-Mims syndrome |
Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200] |
HRAS, KRAS |
Segawa syndrome |
Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
TH |
Seizures |
Febrile seizures, familial, 8 (FEB8) [MIM:607681] |
GABRG2 |
Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745] |
SCN2A |
Severe combined immunodeficiency |
Immunodeficiency 15A (IMD15A) [MIM:618204] |
IKBKB |
Immunodeficiency 43 (IMD43) [MIM:241600] |
B2M |
Immunodeficiency 47 (IMD47) [MIM:300972] |
ATP6AP1 |
Immunodeficiency 48 (IMD48) [MIM:269840] |
ZAP70 |
Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
IL2RG |
Short QT syndrome |
Short QT syndrome 2 (SQT2) [MIM:609621] |
KCNQ1 |
Short QT syndrome 3 (SQT3) [MIM:609622] |
KCNJ2 |
Short stature |
Short stature with microcephaly and distinctive facies (SSMCF) [MIM:615789] |
CRIPT |
Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541] |
XRCC4 |
Shprintzen-Goldberg craniosynostosis syndrome |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
SKI |
Sick sinus syndrome |
Sick sinus syndrome 1 (SSS1) [MIM:608567] |
SCN5A |
Singleton-Merten syndrome |
Singleton-Merten syndrome 2 (SGMRT2) [MIM:616298] |
DDX58 |
Snijders Blok-Campeau syndrome |
Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205] |
CHD3 |
Solitary median maxillary central incisor |
Solitary median maxillary central incisor (SMMCI) [MIM:147250] |
SHH |
Spastic paraplegia |
Spastic paraplegia 30 (SPG30) [MIM:610357] |
KIF1A |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
SPAST |
Speech-language disorder 1 |
Speech-language disorder 1 (SPCH1) [MIM:602081] |
FOXP2 |
Spinal muscular atrophy |
Spinal muscular atrophy 1 (SMA1) [MIM:253300] |
SMN1 |
Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600] |
DYNC1H1 |
Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290] |
BICD2 |
Spinal muscular atrophy, proximal, adult, autosomal dominant (SMAPAD) [MIM:182980] |
VAPB |
Split-hand/foot malformation |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
TP63 |
Spondyloepimetaphyseal dysplasia |
Spondyloepimetaphyseal dysplasia, X-linked (SEMDX) [MIM:300106] |
BGN |
Stormorken syndrome |
Stormorken syndrome (STRMK) [MIM:185070] |
STIM1 |
Subcortical heterotopia |
Subcortical band heterotopia (SBH) [MIM:607432] |
PAFAH1B1 |
Supranuclear palsy |
Progressive supranuclear palsy 1 (PSNP1) [MIM:601104] |
MAPT |
Sveinsson chorioretinal atrophy |
Sveinsson chorioretinal atrophy (SCRA) [MIM:108985] |
TEAD1 |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
NOG |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
DNMT3A |
Thalassemia |
Beta-thalassemia (B-THAL) [MIM:613985] |
HBB |
Thanatophoric dysplasia |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
FGFR3 |
Thanatophoric dysplasia 2 (TD2) [MIM:187601] |
FGFR3 |
Thrombophilia |
Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356] |
SERPIND1 |
Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860] |
PROC |
Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304] |
PROC |
Thrombophilia, X-linked, due to factor IX defect (THPH8) [MIM:300807] |
F9 |
Thyroid dyshormonogenesis |
Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650] |
THRB |
Tonne-Kalscheuer syndrome |
Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978] |
RLIM |
Treacher Collins syndrome |
Treacher Collins syndrome 2 (TCS2) [MIM:613717] |
POLR1D |
Trichothiodystrophy |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
ERCC2 |
Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395] |
GTF2H5 |
Triosephosphate isomerase deficiency |
Triosephosphate isomerase deficiency (TPID) [MIM:615512] |
TPI1 |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
TSC1 |
Usher syndrome |
Usher syndrome 1G (USH1G) [MIM:606943] |
USH1G |
Van Esch-O'Driscoll syndrome |
Van Esch-O'Driscoll syndrome (VEODS) [MIM:301030] |
POLA1 |
Ventricular tachycardia |
Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916] |
CALM1 |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
FZD4 |
Vohwinkel syndrome |
Vohwinkel syndrome (VOWNKL) [MIM:124500] |
GJB2 |
Von Willebrand disease |
Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
GP1BA |
Waardenburg syndrome |
Waardenburg syndrome 1 (WS1) [MIM:193500] |
PAX3 |
Waardenburg syndrome 2E (WS2E) [MIM:611584] |
SOX10 |
Waardenburg syndrome 3 (WS3) [MIM:148820] |
PAX3 |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
EZH2 |
White sponge nevus |
White sponge nevus 1 (WSN1) [MIM:193900] |
KRT4 |
Wilms tumor |
Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272] |
DICER1 |
Wilms tumor 1 (WT1) [MIM:194070] |
WT1 |
Wolff-Parkinson-White syndrome |
Wolff-Parkinson-White syndrome (WPWS) [MIM:194200] |
PRKAG2 |
Xeroderma pigmentosum |
Xeroderma pigmentosum complementation group B (XP-B) [MIM:610651] |
ERCC3 |
Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
ERCC2 |
Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740] |
DDB2 |
Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
ERCC4 |
Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
POLH |
Yao syndrome |
Yao syndrome (YAOS) [MIM:617321] |
NOD2 |
Zimmermann-Laband syndrome |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
KCNH1 |
Zinc deficiency |
Zinc deficiency, transient neonatal (TNZD) [MIM:608118] |
SLC30A2 |
[Show all]
|
Diseases with mutations on the two sides of the same interaction |
Disease | Phenotype | Relevant interactions |
---|
ADULT syndrome |
Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285] |
(TP53,TP63) |
Achondroplasia |
Achondroplasia (ACH) [MIM:100800] |
(FGFR2,FGFR3) |
Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM:616482] |
(FGFR2,FGFR3) |
Acrodysostosis |
Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800] |
(PRKAR1A,PRKACA) |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
(GNB1,GNAS) |
Adrenal hypoplasia, congenital (AHC) [MIM:300200] |
(NR0B1,NR5A1), (PPARG,NR0B1) |
Afibrinogenemia |
Congenital afibrinogenemia (CAFBN) [MIM:202400] |
(F2,FGA), (FGA,FGG), (FGB,FGG), (FGA,FGB) |
Agammaglobulinemia |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
(MET,BTK) |
Age-related macular degeneration |
Macular degeneration, age-related, 3 (ARMD3) [MIM:608895] |
(EFEMP2,FBLN5) |
Macular degeneration, age-related, 4 (ARMD4) [MIM:610698] |
(C3,CFH) |
Neuropathy, hereditary, with or without age-related macular degeneration (HNARMD) [MIM:608895] |
(EFEMP2,FBLN5) |
Aicardi-Goutieres syndrome |
Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181] |
(RNASEH2B,RNASEH2C), (RNASEH2A,RNASEH2B) |
Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329] |
(RNASEH2B,RNASEH2C), (RNASEH2A,RNASEH2C) |
Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333] |
(RNASEH2A,RNASEH2C), (RNASEH2A,RNASEH2B) |
Alexander disease |
Alexander disease (ALXDRD) [MIM:203450] |
(GFAP,DES), (VIM,GFAP) |
Alzheimer disease |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP,PSEN1), (APP,PSEN2) |
Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
(NDUFS8,MT-ND1) |
Alzheimer disease 3 (AD3) [MIM:607822] |
Alzheimer disease 3 (AD3) [MIM:607822] |
(APP,PSEN1) |
Alzheimer disease 4 (AD4) [MIM:606889] |
Alzheimer disease 4 (AD4) [MIM:606889] |
(APP,PSEN2) |
Antithrombin III deficiency |
Antithrombin III deficiency (AT3D) [MIM:613118] |
(F9,SERPINC1), (F10,SERPINC1), (F2,SERPINC1) |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
(CALM1,MYLK) |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
(FGF10,FGFR2) |
Arthrogryposis |
Arthrogryposis, distal, 1A (DA1A) [MIM:108120] |
(TPM2,TPM1) |
Arthrogryposis, distal, 2B4 (DA2B4) [MIM:108120] |
(TPM2,TPM1) |
Atrial septal defect |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
(SCN2B,SCN2A) |
Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980] |
(KCNJ18,KCNJ2) |
Autoimmune disease, multisystem, infantile-onset, |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
(STAT3,STAT1) |
Coffin-Siris syndrome 4 (CSS4) [MIM:614609] |
(SMARCA4,CHD4) |
Autoimmune lymphoproliferative syndrome |
Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859] |
(CALM1,FAS), (FAS,FADD) |
Bardet-Biedl syndrome |
Bardet-Biedl syndrome 1 (BBS1) [MIM:209900] |
(BBS7,BBS1), (BBS1,BBS4) |
Bardet-Biedl syndrome 10 (BBS10) [MIM:615987] |
(BBS12,BBS10) |
Bardet-Biedl syndrome 2 (BBS2) [MIM:615981] |
(BBS7,BBS2) |
Bardet-Biedl syndrome 4 (BBS4) [MIM:615982] |
(BBS1,BBS4) |
Bardet-Biedl syndrome 7 (BBS7) [MIM:615984] |
(BBS7,BBS2), (BBS7,BBS1) |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
(BBS12,BBS10) |
Bart-Pumphrey syndrome |
Bart-Pumphrey syndrome (BAPS) [MIM:149200] |
(GJB1,GJB2), (GJB2,GJA8) |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
(FGFR2,FGFR3), (FGFR3,FGF9) |
Bleeding disorder |
Bleeding disorder, platelet-type 11 (BDPLT11) [MIM:614201] |
(COL1A1,GP6) |
Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800] |
(ITGB3,ITGA2B) |
Bosch-Boonstra-Schaaf optic atrophy syndrome |
Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722] |
(ESR1,NR2F1) |
Brachydactyly |
Brachydactyly A1, C (BDA1C) [MIM:615072] |
(GDF5,HJV), (GDF5,NOG) |
Brachydactyly B2 (BDB2) [MIM:611377] |
(GDF5,NOG) |
Brachydactyly C (BDC) [MIM:113100] |
(GDF5,NOG) |
Breast cancer |
Breast cancer (BC) [MIM:114480] |
(PIK3R1,PIK3CA) |
Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399] |
(RAD51C,RAD51) |
Bronchiectasis |
Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400] |
(SCNN1A,SCNN1B) |
Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021] |
(SCNN1A,SCNN1B) |
Brugada syndrome |
Brugada syndrome 1 (BRGDA1) [MIM:601144] |
(CALM1,SCN5A) |
Camptodactyly tall stature and hearing loss syndrome |
Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM:610474] |
(FGFR2,FGFR3) |
Cardiofaciocutaneous syndrome |
Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150] |
(NRAS,BRAF), (BRAF,YWHAG) |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
(KRAS,SOS1), (KRAS,NF1) |
Cardiomyopathy |
Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200] |
(LMNA,LMNB2), (KRT6A,LMNA), (BANF1,LMNA) |
Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494] |
(TPM1,TNNT2) |
Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286] |
(CALM2,TNNI3), (TNNI3,TNNC1), (TNNI3,TNNT2) |
Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642] |
(SDHB,SDHA) |
Cardiomyopathy, dilated 1II (CMD1II) [MIM:615184] |
(CRYAA,CRYAB) |
Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426] |
(MYH7,XRCC4), (MYL3,MYH7) |
Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878] |
(TPM1,ACTC1) |
Cardiomyopathy, dilated 1Z (CMD1Z) [MIM:611879] |
(TNNI3,TNNC1) |
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
(LMNA,LMNB2) |
Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600] |
(MYL2,MYH7), (MYH7,XRCC4), (MYL3,MYH7) |
Cardiomyopathy, familial hypertrophic 10 (CMH10) [MIM:608758] |
(MYL2,MYH7) |
Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098] |
(TPM1,ACTC1) |
Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243] |
(TNNT2,TNNC1), (TNNI3,TNNC1) |
Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195] |
(TNNT2,TNNC1), (TPM1,TNNT2), (TNNI3,TNNT2) |
Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196] |
(TPM2,TPM1) |
Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690] |
(CALM2,TNNI3), (TNNI3,TNNC1) |
Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751] |
(MYL3,MYH7) |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
(CALM2,TNNI3), (TNNI3,TNNC1) |
Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197] |
Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197] |
(ACTG1,MYBPC3) |
Cataract |
Cataract 1, multiple types (CTRCT1) [MIM:116200] |
(GJB2,GJA8) |
Cataract 30, multiple types (CTRCT30) [MIM:116300] |
(VIM,GFAP) |
Cataract 9, multiple types (CTRCT9) [MIM:604219] |
(CRYAA,CRYAB), (CRYAA,HSPB1) |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450] |
(POLG,POLG2) |
Cerebral amyloid angiopathy |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP,PSEN1) |
Cerebrooculofacioskeletal syndrome |
Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758] |
(ERCC1,ERCC4) |
Cervical cancer |
Cervical cancer (CERCA) [MIM:603956] |
(FGFR3,FGF9) |
Charcot-Marie-Tooth disease |
Charcot-Marie-Tooth disease 2F (CMT2F) [MIM:606595] |
(CRYAB,HSPB1), (CRYAA,HSPB1) |
Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800] |
(GJB1,GJB2) |
Coagulation factor deficiency |
Factor II deficiency (FA2D) [MIM:613679] |
(F2,GP1BA), (F2,FGB), (F2,FGA), (F2,PROC), (F2,SERPIND1), (F2,SERPINC1) |
Factor VII deficiency (FA7D) [MIM:227500] |
(F7,POGLUT1) |
Cohen-Gibson syndrome |
Cohen-Gibson syndrome (COGIS) [MIM:617561] |
(EED,EZH2) |
Colorectal cancer |
Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470] |
(HRAS,SOS1), (HRAS,NF1) |
Colorectal cancer (CRC) [MIM:114500] |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF,YWHAG), (PIK3R1,PIK3CA) |
Complement factors deficiency |
Complement factor H deficiency (CFHD) [MIM:609814] |
(C3,CFH), (CFI,CFH) |
Cone-rod dystrophy |
Cone dystrophy retinal 3B (RCD3B) [MIM:610356] |
(KCNB1,KCNV2) |
Congenital clubfoot |
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly (CCF) [MIM:119800] |
(MSX2,PITX1) |
Congenital heart defects |
Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159] |
(SMARCA4,CHD4) |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
(WAS,CDC42) |
Cornelia de Lange syndrome |
Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470] |
(SMC1A,NIPBL) |
Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590] |
(SMC1A,NIPBL) |
Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701] |
(RAD21,STAG2), (RAD21,STAG1) |
Cortical dysplasia complex with other brain malformations |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
(TUBB3,TUBA1A) |
Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771] |
(TUBB,TUBA1A) |
Cowden disease |
Cowden syndrome 5 (CWS5) [MIM:615108] |
(PIK3R1,PIK3CA) |
Craniosynostosis |
Craniosynostosis 3 (CRS3) [MIM:615314] |
(TWIST2,TCF12) |
Crouzon syndrome |
Crouzon syndrome (CS) [MIM:123500] |
(FGF10,FGFR2), (FGFR2,FGFR3) |
Cutis laxa |
Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100] |
(EFEMP2,FBLN5) |
Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437] |
(EFEMP2,FBLN5) |
Deafness |
Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717] |
(ACTG1,MYBPC3) |
Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544] |
(GJB1,GJB2), (GJB2,GJA8) |
Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290] |
(GJB1,GJB2), (GJB2,GJA8) |
Dehydrated hereditary stomatocytosis 2 |
Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689] |
(KCNN4,CALM1) |
Dementia |
Frontotemporal dementia (FTD) [MIM:600274] |
(MAPT,TUBB3), (MAPT,TUBA1A) |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439] |
(OPTN,TBK1) |
Diabetes mellitus |
Diabetes mellitus, permanent neonatal 2 (PNDM2) [MIM:618856] |
(ABCC8,KCNJ11) |
Diabetes mellitus, permanent neonatal 3 (PNDM3) [MIM:618857] |
(ABCC8,KCNJ11) |
Diabetes mellitus, permanent neonatal 4 (PNDM4) [MIM:618858] |
(INS,INSR) |
Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582] |
(ABCC8,KCNJ11) |
Dowling-Degos disease |
Dowling-Degos disease 4 (DDD4) [MIM:615696] |
(F7,POGLUT1) |
Du Pan syndrome |
Du Pan syndrome (DUPANS) [MIM:228900] |
(GDF5,HJV), (GDF5,NOG) |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(FGA,FGB), (F2,FGB), (F2,FGA), (FGB,FGG), (FGA,FGG) |
Ehlers-Danlos syndrome |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
(COL3A1,SPARC) |
Elliptocytosis |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1,SPTB) |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTA1,SPTB) |
Emery-Dreifuss muscular dystrophy |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
(LMNA,LMNB2), (KRT6A,LMNA), (BANF1,LMNA) |
Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516] |
(LMNA,LMNB2) |
Enhanced S cone syndrome |
Enhanced S cone syndrome (ESCS) [MIM:268100] |
(PPARG,NR2E3) |
Epidermolysis bullosa |
Epidermolysis bullosa simplex, Dowling-Meara type (DM-EBS) [MIM:131760] |
(KRT14,KRT81), (KRT14,KRT5), (KRT16,KRT5), (KRT86,KRT14), (KRT5,KRT25), (KRT14,KRT3) |
Epidermolysis bullosa simplex, Koebner type (K-EBS) [MIM:131900] |
(KRT14,KRT81), (KRT14,KRT5), (KRT16,KRT5), (KRT86,KRT14), (KRT5,KRT25), (KRT14,KRT3) |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14,KRT81), (KRT14,KRT5), (KRT16,KRT5), (KRT86,KRT14), (KRT5,KRT25), (KRT14,KRT3) |
Epidermolysis bullosa simplex, autosomal recessive 1 (EBSB1) [MIM:601001] |
(KRT14,KRT5), (KRT16,KRT5), (KRT5,KRT25) |
Epidermolytic hyperkeratosis |
Epidermolytic hyperkeratosis (EHK) [MIM:113800] |
(KRT1,KRT10) |
Epilepsy |
Epilepsy, childhood absence 2 (ECA2) [MIM:607681] |
(GABRG2,GABRB2), (GABRG2,GABRB3) |
Epilepsy, focal, with speech disorder and with or without mental retardation (FESD) [MIM:245570] |
(GRIN1,GRIN2A) |
Epilepsy, nocturnal frontal lobe, 1 (ENFL1) [MIM:600513] |
(CHRNB2,CHRNA4) |
Epilepsy, nocturnal frontal lobe, 3 (ENFL3) [MIM:605375] |
(CHRNB2,CHRNA4) |
Generalized epilepsy with febrile seizures plus 2 (GEFS+2) [MIM:604403] |
(SCN1A,FGF12) |
Generalized epilepsy with febrile seizures plus 3 (GEFS+3) [MIM:607681] |
(GABRG2,GABRB2), (GABRG2,GABRB3) |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
(STX1B,STXBP1) |
Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
(SCN1A,FGF12) |
Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136] |
(GABRA1,GABRB2), (GABRA1,GABRB3), (GABRA1,GABRG2) |
Epileptic encephalopathy |
Epileptic encephalopathy, early infantile, 11 (EIEE11) [MIM:613721] |
(SCN2B,SCN2A) |
Epileptic encephalopathy, early infantile, 19 (EIEE19) [MIM:615744] |
(GABRA1,GABRB2), (GABRA1,GABRB3), (GABRA1,GABRG2) |
Epileptic encephalopathy, early infantile, 26 (EIEE26) [MIM:616056] |
(KCNH1,KCNB1), (KCNB1,KCNV2) |
Epileptic encephalopathy, early infantile, 4 (EIEE4) [MIM:612164] |
(STX1B,STXBP1) |
Epileptic encephalopathy, early infantile, 43 (EIEE43) [MIM:617113] |
(GABRG2,GABRB3), (GABRA1,GABRB3), (GABRB3,GABRA5) |
Epileptic encephalopathy, early infantile, 47 (EIEE47) [MIM:617166] |
(SCN1A,FGF12), (FGF12,SCN5A) |
Epileptic encephalopathy, early infantile, 56 (EIEE56) [MIM:617665] |
(YWHAG,LRRK2), (RAF1,YWHAG), (BRAF,YWHAG) |
Epileptic encephalopathy, early infantile, 6 (EIEE6) [MIM:607208] |
(SCN1A,FGF12) |
Epileptic encephalopathy, early infantile, 7 (EIEE7) [MIM:613720] |
(KCNQ2,CALM3), (KCNQ2,CALM1) |
Epileptic encephalopathy, early infantile, 74 (EIEE74) [MIM:618396] |
(GABRG2,GABRB2), (GABRG2,GABRB3), (GABRA1,GABRG2) |
Epileptic encephalopathy, infantile or early childhood, 2 (IECEE2) [MIM:617829] |
(GABRG2,GABRB2), (GABRA1,GABRB2) |
Epileptic encephalopathy, early infantile, |
Epileptic encephalopathy, early infantile, 79 (EIEE79) [MIM:618559] |
(GABRB3,GABRA5) |
Erythrocytosis |
Erythrocytosis, familial, 3 (ECYT3) [MIM:609820] |
(EPAS1,EGLN1) |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(VHL,EPAS1), (EPAS1,EGLN1) |
Estrogen resistance |
Estrogen resistance (ESTRR) [MIM:615363] |
(ESR1,NR2F1) |
Exudative vitreoretinopathy |
Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390] |
(NDP,FZD4) |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS,SOS1), (HRAS,NF1) |
Factor X deficiency (FA10D) [MIM:227600] |
Factor X deficiency (FA10D) [MIM:227600] |
(F10,SERPINC1) |
Familial hyperproinsulinemia |
Hyperproinsulinemia (HPRI) [MIM:616214] |
(INS,INSR) |
Fanconi anemia |
Fanconi anemia complementation group Q (FANCQ) [MIM:615272] |
(ERCC1,ERCC4) |
Fanconi anemia, complementation group R (FANCR) [MIM:617244] |
(RAD51C,RAD51) |
Feingold syndrome |
Feingold syndrome 1 (FGLDS1) [MIM:164280] |
(MYCN,MAX) |
Fibrosis of extraocular muscles |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
(MAPT,TUBB3) |
Focal facial dermal dysplasia |
Focal facial dermal dysplasia 3, Setleis type (FFDD3) [MIM:227260] |
(TWIST2,TCF12), (TCF4,TWIST2) |
GM1/2-gangliosidosis |
GM2-gangliosidosis 1 (GM2G1) [MIM:272800] |
(HEXA,HEXB) |
GM2-gangliosidosis 2 (GM2G2) [MIM:268800] |
(HEXA,HEXB) |
Gastric cancer |
Gastric cancer (GASC) [MIM:613659] |
(KRAS,SOS1), (KRAS,NF1) |
Germ cell tumor |
Testicular germ cell tumor (TGCT) [MIM:273300] |
(FGFR2,FGFR3) |
Glanzmann thrombasthenia |
Glanzmann thrombasthenia (GT) [MIM:273800] |
(ITGB3,ITGA2B) |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
(OPTN,TBK1) |
Glioma (GLM) [MIM:137800] |
Glioma (GLM) [MIM:137800] |
(KDM6B,H3C1) |
Glutaric aciduria |
Glutaric aciduria 2A (GA2A) [MIM:231680] |
(ETFA,ETFB) |
Glutaric aciduria 2B (GA2B) [MIM:231680] |
(ETFA,ETFB) |
Griscelli syndrome |
Griscelli syndrome 2 (GS2) [MIM:607624] |
(RAB27A,MLPH) |
Griscelli syndrome 3 (GS3) [MIM:609227] |
(RAB27A,MLPH) |
Growth hormone deficiency |
Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781] |
(GH1,GHR), (GH1,PRLR) |
Growth hormone deficiency, isolated, 2 (IGHD2) [MIM:173100] |
(GH1,GHR), (GH1,PRLR) |
Growth hormone insensitivity |
Growth hormone insensitivity, partial (GHIP) [MIM:604271] |
(GH1,GHR) |
Growth retardation |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2B,CSNK2A1) |
Hartsfield syndrome |
Hartsfield syndrome (HRTFDS) [MIM:615465] |
(FGFR1,FGF9) |
Heimler syndrome |
Heimler syndrome 2 (HMLR2) [MIM:616617] |
(PEX1,PEX6) |
Hemochromatosis |
Hemochromatosis 2A (HFE2A) [MIM:602390] |
(GDF5,HJV) |
Hemochromatosis 2B (HFE2B) [MIM:613313] |
(HAMP,SLC40A1) |
Hemochromatosis 4 (HFE4) [MIM:606069] |
(HAMP,SLC40A1) |
Hemolytic uremic syndrome |
Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400] |
(C3,CFH) |
Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922] |
(C3,CD46) |
Hemolytic uremic syndrome atypical 3 (AHUS3) [MIM:612923] |
(CFI,CFH) |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
(C3,CD46), (C3,CFH) |
Hemophilia A (HEMA) [MIM:306700] |
Hemophilia A (HEMA) [MIM:306700] |
(F8,VWF) |
Hemophilia B (HEMB) [MIM:306900] |
Hemophilia B (HEMB) [MIM:306900] |
(F9,SERPINC1) |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET,BTK), (PIK3R1,PIK3CA) |
Hirschsprung disease |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET,GDNF) |
Hirschsprung disease 3 (HSCR3) [MIM:613711] |
(RET,GDNF) |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
(LMNA,LMNB2), (BANF1,LMNA) |
Hypercholesterolemia |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(LDLR,PCSK9) |
Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890] |
Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890] |
(LDLR,PCSK9) |
Hyperinsulinemic hypoglycemia |
Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450] |
(ABCC8,KCNJ11) |
Familial hyperinsulinemic hypoglycemia 2 (HHF2) [MIM:601820] |
(ABCC8,KCNJ11) |
Leucine-induced hypoglycemia (LIH) [MIM:240800] |
(ABCC8,KCNJ11) |
Hyperlipoproteinemia |
Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947] |
(LPL,GPIHBP1) |
Hyperprolactinemia |
Hyperprolactinemia (HPRL) [MIM:615555] |
(GH1,PRLR) |
Hypocalcemia |
Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361] |
(GNA11,GNB1) |
Hypochondroplasia |
Hypochondroplasia (HCH) [MIM:146000] |
(FGFR2,FGFR3) |
Hypogonadotropic hypogonadism |
Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] |
(FGFR1,FGF9) |
Hystrix-like ichthyosis with deafness |
Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540] |
(GJB1,GJB2), (GJB2,GJA8) |
Ichthyosis |
Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
(KRT1,KRT10) |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2,KRT25), (KRT16,KRT2) |
Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277] |
(ABCA1,ABCA12) |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12,EZH2) |
Immunodeficiency |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
(STAT3,STAT1) |
Infections recurrent associated with encephalopathy hepatic dysfunction and cardiovascular malformations |
Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759] |
(FAS,FADD) |
Intellectual developmental disorder with hypotonia and behavioral abnormalities |
Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748] |
(BMPR1A,CDK8) |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
(TRIO,RAC1) |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
(FGF10,FGFR2), (FGFR1,FGF9) |
Jervell and Lange-Nielsen syndrome |
Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400] |
(KCNE1,KCNQ1) |
Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347] |
(KCNE1,KCNQ1) |
Juvenile polyposis |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
(BMPR1A,CDK8), (SMAD3,SMAD4) |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
(SMAD3,SMAD4) |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS,BRAF), (FGFR3,FGF9) |
Keratitis-ichthyosis-deafness syndrome |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB1,GJB2), (GJB2,GJA8) |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3R1,PIK3CA), (FGFR2,FGFR3), (FGFR3,FGF9) |
Lacrimo-auriculo-dento-digital syndrome |
Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
(FGF10,FGFR2), (FGFR2,FGFR3) |
Laron syndrome |
Laron syndrome (LARS) [MIM:262500] |
(GH1,GHR) |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
(MT-CO1,MT-CO3), (MT-ND4L,MT-ND6) |
Leber optic neuropathy |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
(MT-ND3,MT-ND6) |
Left ventricular non-compaction |
Left ventricular non-compaction 9 (LVNC9) [MIM:611878] |
(TPM1,TNNT2), (TPM1,ACTC1) |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
(MYH7,XRCC4) |
Leigh syndrome |
Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
(PDHA1,PDHB) |
Leigh syndrome (LS) [MIM:256000] |
Leigh syndrome (LS) [MIM:256000] |
(MT-ND3,MT-ND6), (MT-ND4L,MT-ND6), (POLG,POLG2) |
Leopard syndrome |
LEOPARD syndrome 2 (LPRD2) [MIM:611554] |
(RAF1,YWHAG) |
Leprechaunism |
Leprechaunism (LEPRCH) [MIM:246200] |
(INS,INSR) |
Leukemia |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS,SOS1), (KRAS,NF1) |
Leukodystrophy hypomyelinating |
Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494] |
(POLR1C,POLR3B), (POLR1C,POLR1D), (POLR3A,POLR1C) |
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
(POLR3A,POLR1D), (POLR3A,POLR1C) |
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381] |
(POLR1C,POLR3B) |
Leukodystrophy with vanishing white matter |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
(EIF2B3,EIF2B4), (EIF2B2,EIF2B4), (EIF2B5,EIF2B4) |
Li-Fraumeni syndrome |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53,TP63) |
Limb-girdle muscular dystrophy |
Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
(LMNA,LMNB2), (KRT6A,LMNA) |
Lipodystrophy |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
(LMNA,LMNB2), (BANF1,LMNA) |
Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367] |
(PPARG,NR2E3), (PPARG,NR0B1) |
Partial acquired lipodystrophy (APLD) [MIM:608709] |
(LMNA,LMNB2) |
Lipoprotein lipase deficiency |
Hyperlipoproteinemia 1 (HLPP1) [MIM:238600] |
(LPL,GPIHBP1) |
Lissencephaly |
Lissencephaly 3 (LIS3) [MIM:611603] |
(TUBB,TUBA1A), (MAPT,TUBA1A), (TUBB3,TUBA1A) |
Loeys-Dietz syndrome |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
(SMAD3,SMAD4) |
Long QT syndrome |
Long QT syndrome 1 (LQT1) [MIM:192500] |
(KCNE1,KCNQ1), (CALM2,KCNQ1), (CALM1,KCNQ1) |
Long QT syndrome 14 (LQT14) [MIM:616247] |
(CALM1,FAS), (CALM1,MYLK), (KCNN4,CALM1), (CALM1,SCN5A), (KCNQ2,CALM1), (CALM1,KCNQ1) |
Long QT syndrome 15 (LQT15) [MIM:616249] |
(CALM2,TNNI3), (CALM2,KCNQ1) |
Long QT syndrome 16 (LQT16) [MIM:618782] |
(KCNQ2,CALM3) |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ18,KCNJ2) |
Long QT syndrome 3 (LQT3) [MIM:603830] |
Long QT syndrome 3 (LQT3) [MIM:603830] |
(FGF12,SCN5A), (CALM1,SCN5A) |
Mandibuloacral dysplasia |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
(BANF1,LMNA) |
Mandibulofacial dysostosis with alopecia |
Mandibulofacial dysostosis with alopecia (MFDA) [MIM:616367] |
(EDN1,EDNRA) |
Maple syrup urine disease |
Maple syrup urine disease 1A (MSUD1A) [MIM:248600] |
(BCKDHA,BCKDHB) |
Maple syrup urine disease 1B (MSUD1B) [MIM:248600] |
(BCKDHA,BCKDHB) |
Maturity-onset diabetes of the young |
Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370] |
(INS,INSR) |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNB1,GNAS) |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET,GDNF) |
Meesmann corneal dystrophy |
Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767] |
(KRT16,KRT3), (KRT14,KRT3) |
Megalencephaly-capillary malformation-polymicrogyria syndrome |
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501] |
(PIK3R1,PIK3CA) |
Meier-Gorlin syndrome |
Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690] |
(ORC4,ORC1) |
Meier-Gorlin syndrome 2 (MGORS2) [MIM:613800] |
(ORC4,ORC1) |
Melanoma |
Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601] |
(CDK4,CDKN2A) |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4,CDKN2A) |
Mental retardation |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1,GNAS), (GNA11,GNB1) |
Mental retardation, autosomal dominant 47 (MRD47) [MIM:617635] |
(RAD21,STAG1) |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(TRIO,RAC1) |
Metachromatic leukodystrophy |
Metachromatic leukodystrophy (MLD) [MIM:250100] |
(ARSA,SUMF1) |
Microcephaly-capillary malformation syndrome |
Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261] |
(PRKN,STAMBP) |
Mitochondrial DNA depletion syndrome |
Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700] |
(POLG,POLG2) |
Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662] |
(POLG,POLG2) |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
(MT-CO1,MT-CO3) |
Mitochondrial complex deficiency |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
(MT-ND3,MT-ND6) |
Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222] |
(NDUFS8,MT-ND1), (NDUFS8,NDUFS6), (NDUFS8,NDUFS2) |
Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228] |
(NDUFS8,NDUFS2) |
Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232] |
(NDUFS8,NDUFS6) |
Mitochondrial complex II deficiency (MT-C2D) [MIM:252011] |
(SDHB,SDHA) |
Mitochondrial complex V deficiency, nuclear type 3 (MC5DN3) [MIM:614053] |
(ATP5F1D,ATP5F1E) |
Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) [MIM:618120] |
(ATP5F1D,ATP5F1E) |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
(MT-ND3,MT-ND6), (MT-ND4L,MT-ND6), (NDUFS8,MT-ND1) |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
(KRT14,KRT81), (KRT16,KRT81), (KRT86,KRT14), (KRT16,KRT83), (KRT86,KRT16) |
Muenke syndrome |
Muenke syndrome (MNKS) [MIM:602849] |
(FGFR3,FGF9) |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
(RAD21,STAG2) |
Multiple neoplasia |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET,GDNF) |
Multiple sulfatase deficiency |
Multiple sulfatase deficiency (MSD) [MIM:272200] |
(ARSA,SUMF1) |
Multiple synostoses syndrome |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5,HJV), (GDF5,NOG) |
Multiple synostoses syndrome 3 (SYNS3) [MIM:612961] |
(FGFR1,FGF9), (FGFR3,FGF9) |
Myasthenic syndrome |
Myasthenic syndrome, congenital, 18 (CMS18) [MIM:616330] |
(SNAP25,VAMP2) |
Myopathy |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS,SOS1), (HRAS,NF1) |
Myopathy, distal, 1 (MPD1) [MIM:160500] |
(MYH7,XRCC4) |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(GFAP,DES) |
Myopathy, myofibrillar, 2 (MFM2) [MIM:608810] |
(CRYAB,HSPB1), (CRYAA,CRYAB), (CRYAB,HSPB8) |
Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358] |
(MYH7,XRCC4) |
Nemaline myopathy |
Nemaline myopathy 4 (NEM4) [MIM:609285] |
(TPM2,TPM1) |
Nestor-Guillermo progeria syndrome |
Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008] |
(BANF1,LMNA) |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities (NEDCFSA) [MIM:618505] |
(KDM6B,H3C1) |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760] |
(SNAP25,VAMP2) |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN1,GRIN2A) |
Neurofibromatosis |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(KRAS,NF1), (HRAS,NF1) |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(KRAS,NF1), (HRAS,NF1) |
Neuronopathy |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
(CRYAB,HSPB8) |
Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634] |
(CRYAB,HSPB1), (CRYAA,HSPB1) |
Neuropathy |
Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400] |
(SPTLC1,SPTLC2) |
Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640] |
(SPTLC1,SPTLC2) |
Neutropenia |
Neutropenia, severe congenital, X-linked (XLN) [MIM:300299] |
(WAS,CDC42) |
Niemann-Pick disease |
Niemann-Pick disease C1 (NPC1) [MIM:257220] |
(NPC1,NPC2) |
Niemann-Pick disease C2 (NPC2) [MIM:607625] |
(NPC1,NPC2) |
Noonan syndrome |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS,SOS1), (KRAS,NF1) |
Noonan syndrome 4 (NS4) [MIM:610733] |
(KRAS,SOS1), (HRAS,SOS1) |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1,YWHAG) |
Noonan syndrome 6 (NS6) [MIM:613224] |
(NRAS,BRAF) |
Noonan syndrome 7 (NS7) [MIM:613706] |
(BRAF,YWHAG) |
Norrie disease |
Norrie disease (ND) [MIM:310600] |
(NDP,FZD4) |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
(KRAS,SOS1), (KRAS,NF1) |
Osseous heteroplasia |
Progressive osseous heteroplasia (POH) [MIM:166350] |
(GNB1,GNAS) |
Osteogenesis imperfecta |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
(COL1A1,COL1A2) |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
(COL3A1,SPARC) |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
(COL1A1,COL1A2), (COL1A1,GP6) |
Osteogenesis imperfecta 3 (OI3) [MIM:259420] |
(COL1A1,COL1A2), (COL1A1,GP6) |
Osteogenesis imperfecta 4 (OI4) [MIM:166220] |
(COL1A1,COL1A2) |
Pachyonychia congenita |
Pachyonychia congenita 1 (PC1) [MIM:167200] |
(KRT16,KRT3), (KRT16,KRT81), (KRT16,KRT2), (KRT16,KRT5), (KRT6A,KRT16), (KRT16,KRT4), (KRT16,KRT83), (KRT86,KRT16) |
Pachyonychia congenita 2 (PC2) [MIM:167210] |
(KRT6A,KRT17) |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A,KRT16), (KRT6A,LMNA), (KRT6A,KRT17) |
Palmoplantar keratoderma |
Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350] |
(GJB1,GJB2), (GJB2,GJA8) |
Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760] |
(KRT5,KRT25), (KRT2,KRT25) |
Parietal foramina |
Parietal foramina 1 (PFM1) [MIM:168500] |
(MSX2,PITX1), (POU1F1,MSX2) |
Parkinson disease |
Parkinson disease (PARK) [MIM:168600] |
(PRKN,STAMBP) |
Parkinson disease 2 (PARK2) [MIM:600116] |
(PRKN,STAMBP) |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAG,LRRK2), (PRKACA,LRRK2) |
Peroxisome biogenesis disorder |
Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539] |
(PEX1,PEX6) |
Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862] |
(PEX1,PEX6) |
Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862] |
(PEX1,PEX6) |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
(FGF10,FGFR2), (FGFR1,FGF9), (FGFR2,FGFR3) |
Pheochromocytoma (PCC) [MIM:171300] |
Pheochromocytoma (PCC) [MIM:171300] |
(VHL,EPAS1), (MYCN,MAX), (SDHB,SDHA) |
Pigmented adrenocortical disease |
Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830] |
(PRKACA,LRRK2), (PRKACA,SIK3), (PRKAR1A,PRKACA) |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4,TWIST2) |
Pituitary hormone deficiency |
Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038] |
(POU1F1,MSX2) |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
(CSNK2B,CSNK2A1) |
Pontocerebellar hypoplasia |
Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678] |
(EXOSC9,EXOSC3) |
Pontocerebellar hypoplasia 1D (PCH1D) [MIM:618065] |
(EXOSC9,EXOSC3) |
Premature ovarian failure |
Premature ovarian failure 7 (POF7) [MIM:612964] |
(NR0B1,NR5A1) |
Progressive external ophthalmoplegia |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131] |
(POLG,POLG2) |
Pseudohypoaldosteronism |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(WNK4,KLHL3) |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK4,KLHL3) |
Pseudohypoparathyroidism |
Albright hereditary osteodystrophy (AHO) [MIM:103580] |
(GNB1,GNAS) |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
(GNB1,GNAS) |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1,SPTB) |
Pyruvate carboxylase deficiency |
Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111] |
(PDHA1,PDHB) |
Question mark ears |
Question mark ears, isolated (QME) [MIM:612798] |
(EDN1,EDNRA) |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
(INS,INSR) |
Renal cell carcinoma |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET,BTK) |
Retinitis pigmentosa |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
(SNRNP200,PRPF8) |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
(SNRNP200,PRPF8) |
SHORT syndrome |
SHORT syndrome (SHORTS) [MIM:269880] |
(PIK3R1,PIK3CA) |
Scaphocephaly syndrome |
Familial scaphocephaly syndrome (FSPC) [MIM:609579] |
(FGFR2,FGFR3) |
Schimmelpenning-Feuerstein-Mims syndrome |
Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200] |
(KRAS,SOS1), (KRAS,NF1), (HRAS,SOS1) |
Seizures |
Febrile seizures, familial, 8 (FEB8) [MIM:607681] |
(GABRG2,GABRB2), (GABRG2,GABRB3) |
Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745] |
(SCN2B,SCN2A) |
Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200] |
(KCNQ2,CALM3), (KCNQ2,CALM1) |
Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
(POLG,POLG2) |
Short QT syndrome |
Short QT syndrome 3 (SQT3) [MIM:609622] |
(KCNJ18,KCNJ2) |
Short stature |
Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541] |
(MYH7,XRCC4) |
Sick sinus syndrome |
Sick sinus syndrome 1 (SSS1) [MIM:608567] |
(CALM1,SCN5A) |
Sitosterolemia |
Sitosterolemia 1 (STSL1) [MIM:210250] |
(ABCG8,ABCG5) |
Sitosterolemia 2 (STSL2) [MIM:618666] |
(ABCG8,ABCG5) |
Spinocerebellar ataxia |
Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459] |
(POLG,POLG2) |
Spondyloepimetaphyseal dysplasia |
Spondyloepimetaphyseal dysplasia, Krakow type (SEMDK) [MIM:618162] |
(PRKACA,SIK3) |
Symphalangism |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(GDF5,NOG) |
Symphalangism, proximal 1B (SYM1B) [MIM:615298] |
(GDF5,HJV), (GDF5,NOG) |
Tangier disease |
Tangier disease (TGD) [MIM:205400] |
(ABCA1,ABCA12) |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(GDF5,NOG) |
Temple-Baraitser syndrome |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1,KCNB1) |
Thanatophoric dysplasia |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGFR2,FGFR3), (FGFR3,FGF9) |
Thanatophoric dysplasia 2 (TD2) [MIM:187601] |
(FGFR2,FGFR3) |
Thrombophilia |
Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356] |
(F2,SERPIND1) |
Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860] |
(F2,PROC) |
Thyrotoxic hypokalemic periodic paralysis |
Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239] |
(KCNJ18,KCNJ2) |
Treacher Collins syndrome |
Treacher Collins syndrome 2 (TCS2) [MIM:613717] |
(POLR1C,POLR1D), (POLR3A,POLR1D) |
Ventricular tachycardia |
Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916] |
(CALM1,KCNQ1), (CALM1,SCN5A), (KCNQ2,CALM1) |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
(NDP,FZD4) |
Vohwinkel syndrome |
Vohwinkel syndrome (VOWNKL) [MIM:124500] |
(GJB1,GJB2), (GJB2,GJA8) |
Von Hippel-Lindau disease |
Von Hippel-Lindau disease (VHLD) [MIM:193300] |
(VHL,EPAS1) |
Von Willebrand disease |
Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
(F2,GP1BA), (VWF,GP1BA) |
Von Willebrand disease 2 (VWD2) [MIM:613554] |
(F8,VWF), (VWF,GP1BA) |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
(SUZ12,EZH2), (EED,EZH2) |
White sponge nevus |
White sponge nevus 1 (WSN1) [MIM:193900] |
(KRT16,KRT4) |
Xeroderma pigmentosum |
Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
(ERCC1,ERCC4) |
Zimmermann-Laband syndrome |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
(KCNH1,KCNB1) |
[Show all]
|
Diseases having interaction interfaces enriched with mutations |
Disease
| Disease phenotype (**)
| Interaction
| Log_2 Enrich.
| P-val
| Corr. P-val
|
Abetalipoproteinemia |
Abetalipoproteinemia (ABL) [MIM:200100] |
(P4HB, MTTP) |
2.433 |
0.0144 |
0.0144 |
Acyl-CoA dehydrogenase deficiency |
Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475] |
(ACADVL, ACADVL) |
0.811 |
0.0223 |
0.0223 |
All phenotypes |
(ACADVL, ACADVL) |
0.811 |
0.0223 |
0.0893 |
Adenomatous polyposis |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, DLG3) |
4.852 |
0.0342 |
0.0398 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, DLG1) |
4.629 |
0.0398 |
0.0398 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, SCRIB) |
4.629 |
0.0398 |
0.0398 |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
(GNB1, GNAS) |
2.217 |
0.0462 |
0.0925 |
All phenotypes |
(GNB1, GNAS) |
2.217 |
0.0462 |
0.231 |
Adrenocorticotropic hormone deficiency |
ACTH deficiency, isolated (IAD) [MIM:201400] |
(TBX19, VENTX) |
4.939 |
0.0326 |
0.0435 |
ACTH deficiency, isolated (IAD) [MIM:201400] |
(TBX19, PITX1) |
4.524 |
0.0435 |
0.0435 |
ACTH deficiency, isolated (IAD) [MIM:201400] |
(TBX19, TBX6) |
4.524 |
0.0435 |
0.0435 |
Adrenoleukodystrophy |
Adrenoleukodystrophy (ALD) [MIM:300100] |
(ABCD1, ABCD1) |
0.342 |
0.0326 |
0.0977 |
Agammaglobulinemia |
All phenotypes |
(MET, BTK) |
0.581 |
0.0378 |
0.303 |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
(MET, BTK) |
0.581 |
0.0378 |
0.227 |
Alazami-Yuan syndrome |
Alazami-Yuan syndrome (ALYUS) [MIM:617126] |
(TAF6, TAF9) |
2.549 |
0.0292 |
0.0584 |
Alzheimer disease |
All phenotypes |
(APP, PITRM1) |
3.389 |
0.0151 |
0.0544 |
All phenotypes |
(APP, LCN2) |
2.859 |
0.03 |
0.0885 |
All phenotypes |
(APP, PSEN2) |
2.796 |
1.74e-9 |
1.56e-8 |
All phenotypes |
(IGKC, APP) |
2.752 |
0.0344 |
0.0885 |
All phenotypes |
(APP, PSEN1) |
2.226 |
3.05e-19 |
5.49e-18 |
All phenotypes |
(APP, APP) |
1.323 |
6.64e-6 |
3.98e-5 |
All phenotypes |
(NOTCH1, PSEN1) |
0.762 |
0.00136 |
0.00614 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PSEN1) |
4.559 |
9.28e-15 |
9.28e-14 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PSEN2) |
4.181 |
4.79e-12 |
2.39e-11 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PITRM1) |
3.389 |
0.0151 |
0.0377 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, LCN2) |
2.859 |
0.03 |
0.0574 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(IGKC, APP) |
2.752 |
0.0344 |
0.0574 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, APP) |
1.323 |
6.64e-6 |
2.21e-5 |
Alzheimer disease 3 (AD3) [MIM:607822] |
(APP, PSEN1) |
0.900 |
0.000145 |
0.000725 |
Alzheimer disease 3 (AD3) [MIM:607822] |
(NOTCH1, PSEN1) |
0.762 |
0.00136 |
0.00341 |
Amelogenesis imperfecta |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
(TGFB3, ITGB6) |
4.531 |
0.00245 |
0.0056 |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
(TGFB1, ITGB6) |
4.222 |
0.00374 |
0.0056 |
Amyloidosis |
All phenotypes |
(GSN, GSN) |
2.963 |
0.0164 |
0.132 |
Amyloidosis 5 (AMYL5) [MIM:105120] |
(GSN, GSN) |
2.963 |
0.0164 |
0.0164 |
Amyotrophic lateral sclerosis |
All phenotypes |
(SHC1, ERBB4) |
5.705 |
0.0192 |
0.0805 |
All phenotypes |
(FUS, TNPO1) |
3.942 |
5.76e-15 |
1.21e-13 |
All phenotypes |
(HNRNPA1, TNPO1) |
3.099 |
0.0172 |
0.0805 |
All phenotypes |
(HNRNPA1, HNRNPA1) |
2.191 |
0.0105 |
0.0735 |
All phenotypes |
(TARDBP, TARDBP) |
0.976 |
6.9e-7 |
7.24e-6 |
Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069] |
(TARDBP, TARDBP) |
0.976 |
6.9e-7 |
6.9e-7 |
Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515] |
(SHC1, ERBB4) |
5.705 |
0.0192 |
0.0192 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
(HNRNPA1, TNPO1) |
3.099 |
0.0172 |
0.0172 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
(HNRNPA1, HNRNPA1) |
2.191 |
0.0105 |
0.0172 |
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030] |
(FUS, TNPO1) |
3.942 |
5.76e-15 |
5.76e-15 |
Anhidrosis |
Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190] |
(ITPR2, TRPC4) |
5.451 |
0.0229 |
0.0229 |
Antithrombin III deficiency |
Antithrombin III deficiency (AT3D) [MIM:613118] |
(F9, SERPINC1) |
1.000 |
0.0357 |
0.133 |
Aortic aneurysm |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
(CALM1, MYLK) |
4.794 |
0.00171 |
0.00171 |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
(FGF4, FGFR2) |
4.097 |
0.0002 |
0.000888 |
Apert syndrome (APRS) [MIM:101200] |
(FGF10, FGFR2) |
3.945 |
0.000274 |
0.000888 |
Apert syndrome (APRS) [MIM:101200] |
(FGF3, FGFR2) |
3.841 |
0.00034 |
0.000888 |
Apert syndrome (APRS) [MIM:101200] |
(FGF2, FGFR2) |
3.775 |
0.00039 |
0.000888 |
Apert syndrome (APRS) [MIM:101200] |
(FGF5, FGFR2) |
3.712 |
0.000444 |
0.000888 |
Apert syndrome (APRS) [MIM:101200] |
(FGFR2, FGF8) |
3.512 |
0.000674 |
0.00112 |
Apert syndrome (APRS) [MIM:101200] |
(FGF7, FGFR2) |
3.336 |
0.000971 |
0.00139 |
Apert syndrome (APRS) [MIM:101200] |
(FGF1, FGFR2) |
3.057 |
0.00173 |
0.00217 |
Atrial septal defect |
All phenotypes |
(SCN2B, SCN2A) |
3.667 |
0.0062 |
0.062 |
All phenotypes |
(NKX2-5, MEF2A) |
2.000 |
0.0351 |
0.117 |
All phenotypes |
(NKX2-5, MEF2B) |
2.000 |
0.0351 |
0.117 |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
(SCN2B, SCN2A) |
3.667 |
0.0062 |
0.0062 |
Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900] |
(NKX2-5, MEF2A) |
2.000 |
0.0351 |
0.0701 |
Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900] |
(NKX2-5, MEF2B) |
2.000 |
0.0351 |
0.0701 |
Autoimmune disease, multisystem, infantile-onset, |
All phenotypes |
(H2BC12, SMARCB1) |
4.506 |
0.00253 |
0.0278 |
All phenotypes |
(SMARCB1, H2AC18) |
4.381 |
0.000111 |
0.00243 |
All phenotypes |
(STAT3, STAT2) |
2.807 |
0.0278 |
0.204 |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
(STAT3, STAT2) |
2.807 |
0.0278 |
0.187 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(H2BC12, SMARCB1) |
4.506 |
0.00253 |
0.00253 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(SMARCB1, H2AC18) |
4.381 |
0.000111 |
0.000221 |
Autoimmune lymphoproliferative syndrome |
All phenotypes |
(ILK, CASP8) |
4.328 |
0.0498 |
0.204 |
Caspase-8 deficiency (CASP8D) [MIM:607271] |
(ILK, CASP8) |
4.328 |
0.0498 |
0.0498 |
Autoimmune polyendocrine syndrome |
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300] |
(AIRE, AIRE) |
2.106 |
0.0184 |
0.0368 |
Autoinflammation, antibody deficiency, and immune dysregulation |
Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878] |
(ERBB2, PLCG2) |
6.111 |
0.0145 |
0.0289 |
Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878] |
(PLCG2, GRB2) |
4.340 |
0.0494 |
0.0494 |
Bardet-Biedl syndrome |
All phenotypes |
(BBS1, BBS2) |
1.538 |
0.0436 |
0.196 |
All phenotypes |
(BBS1, BBS4) |
1.245 |
0.0316 |
0.196 |
Bardet-Biedl syndrome 2 (BBS2) [MIM:615981] |
(BBS1, BBS2) |
1.538 |
0.0436 |
0.131 |
Basal cell nevus syndrome |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, HLA-A) |
3.503 |
0.00997 |
0.0258 |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, RASA1) |
2.200 |
0.0103 |
0.0258 |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, RGL3) |
1.886 |
0.0198 |
0.033 |
Beta-ureidopropionase deficiency |
Beta-ureidopropionase deficiency (UPB1D) [MIM:613161] |
(UPB1, UPB1) |
1.374 |
0.0465 |
0.0465 |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
(FGFR3, CDK2) |
2.906 |
0.0256 |
0.0914 |
Bladder cancer (BLC) [MIM:109800] |
(FGF1, FGFR3) |
2.683 |
0.0342 |
0.0914 |
Bleeding disorder |
All phenotypes |
(ITGA2B, FLNA) |
7.104 |
5.28e-5 |
0.00037 |
All phenotypes |
(ITGB3, TLN1) |
5.114 |
0.0289 |
0.0674 |
All phenotypes |
(P2RY12, P2RY12) |
2.425 |
0.0424 |
0.0695 |
All phenotypes |
(RAP1B, RASGRP2) |
2.362 |
0.0497 |
0.0695 |
All phenotypes |
(ITGB3, ITGA2B) |
1.885 |
0.0198 |
0.0674 |
Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800] |
(ITGA2B, FLNA) |
7.104 |
5.28e-5 |
0.000159 |
Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800] |
(ITGB3, TLN1) |
5.114 |
0.0289 |
0.0289 |
Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800] |
(ITGB3, ITGA2B) |
1.885 |
0.0198 |
0.0289 |
Bleeding disorder, platelet-type 18 (BDPLT18) [MIM:615888] |
(RAP1B, RASGRP2) |
2.362 |
0.0497 |
0.0497 |
Bleeding disorder, platelet-type 8 (BDPLT8) [MIM:609821] |
(P2RY12, P2RY12) |
2.425 |
0.0424 |
0.0424 |
Blepharocheilodontic syndrome |
Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580] |
(CDH1, CDH1) |
3.780 |
0.0053 |
0.0053 |
Brachycephaly, trichomegaly, and developmental delay |
Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744] |
(KEAP1, NFE2L2) |
2.700 |
0.00561 |
0.0112 |
Brachydactyly |
All phenotypes |
(IHH, CDON) |
2.935 |
0.0235 |
0.0721 |
All phenotypes |
(IHH, BOC) |
2.865 |
0.0257 |
0.0721 |
All phenotypes |
(BMP2, NOG) |
2.014 |
0.00839 |
0.0535 |
All phenotypes |
(BMP7, NOG) |
1.892 |
0.0115 |
0.0535 |
All phenotypes |
(GDF5, NOG) |
1.615 |
0.00201 |
0.0281 |
Brachydactyly A1 (BDA1) [MIM:112500] |
(IHH, CDON) |
2.935 |
0.0235 |
0.0257 |
Brachydactyly A1 (BDA1) [MIM:112500] |
(IHH, BOC) |
2.865 |
0.0257 |
0.0257 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(BMP2, NOG) |
2.014 |
0.00839 |
0.0153 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(GDF5, NOG) |
1.972 |
0.00934 |
0.0153 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(BMP7, NOG) |
1.892 |
0.0115 |
0.0153 |
Breast cancer |
All phenotypes |
(PIK3CA, GRB2) |
6.352 |
0.0122 |
0.0581 |
All phenotypes |
(BRCA2, PALB2) |
4.771 |
1.02e-5 |
0.000193 |
All phenotypes |
(BRCA1, ATRIP) |
3.138 |
0.00384 |
0.0243 |
All phenotypes |
(BRCA1, BRAT1) |
3.138 |
0.00384 |
0.0243 |
All phenotypes |
(BRCA1, ACACA) |
2.264 |
0.0204 |
0.0777 |
All phenotypes |
(BRCA1, ABRAXAS1) |
1.865 |
0.0422 |
0.125 |
All phenotypes |
(BRCA1, BRIP1) |
1.816 |
0.046 |
0.125 |
Breast cancer (BC) [MIM:114480] |
(PIK3CA, GRB2) |
6.352 |
0.0122 |
0.0551 |
Breast cancer (BC) [MIM:114480] |
(BRCA2, PALB2) |
4.771 |
1.02e-5 |
0.000183 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ATRIP) |
3.138 |
0.00384 |
0.023 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, BRAT1) |
3.138 |
0.00384 |
0.023 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ACACA) |
2.264 |
0.0204 |
0.0736 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ABRAXAS1) |
1.865 |
0.0422 |
0.118 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, BRIP1) |
1.816 |
0.046 |
0.118 |
Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370] |
(BRCA1, BARD1) |
3.023 |
0.0151 |
0.0151 |
Camurati-Engelmann disease |
Camurati-Engelmann disease (CAEND) [MIM:131300] |
(TGFB1, TGFB1) |
0.850 |
0.0161 |
0.0161 |
Cardiofaciocutaneous syndrome |
All phenotypes |
(KRAS, SOS1) |
1.495 |
0.00563 |
0.107 |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
(KRAS, SOS1) |
1.495 |
0.00563 |
0.0338 |
Cardiomyopathy |
All phenotypes |
(BAG3, HSPA1A) |
2.392 |
0.0104 |
0.12 |
All phenotypes |
(BAG3, HSPA8) |
2.200 |
0.0153 |
0.12 |
All phenotypes |
(MYL3, MYH7) |
1.486 |
9.28e-10 |
4.45e-8 |
All phenotypes |
(TPM1, TNNI3) |
1.414 |
0.00292 |
0.0467 |
All phenotypes |
(LMNA, LMNB2) |
0.841 |
0.0147 |
0.12 |
All phenotypes |
(LMNA, LMNB1) |
0.810 |
0.0176 |
0.12 |
All phenotypes |
(LMNA, LMNA) |
0.663 |
0.00225 |
0.0467 |
Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158] |
(ACTN2, ACTB) |
4.552 |
0.0426 |
0.0426 |
Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200] |
(LMNA, LMNB2) |
0.836 |
0.0193 |
0.0532 |
Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200] |
(LMNA, LMNB1) |
0.805 |
0.0228 |
0.0532 |
Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200] |
(LMNA, LMNA) |
0.629 |
0.00574 |
0.0402 |
Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494] |
(TPM1, TNNT2) |
2.420 |
0.0427 |
0.0427 |
Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881] |
(BAG3, HSPA1A) |
2.392 |
0.0104 |
0.0153 |
Cardiomyopathy, dilated 1HH (CMD1HH) [MIM:613881] |
(BAG3, HSPA8) |
2.200 |
0.0153 |
0.0153 |
Cardiomyopathy, dilated 1R (CMD1R) [MIM:613424] |
(CAPN1, ACTC1) |
5.229 |
0.0265 |
0.0265 |
Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098] |
(ACTC1, DBN1) |
2.644 |
0.0381 |
0.0763 |
Cardiomyopathy, familial hypertrophic 11 (CMH11) [MIM:612098] |
(CFL1, ACTC1) |
1.718 |
0.0224 |
0.0763 |
Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600] |
(MYL3, MYH7) |
2.252 |
2.09e-15 |
1.05e-14 |
Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690] |
(TPM1, TNNI3) |
1.617 |
0.00643 |
0.0257 |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
(TPM1, TNNI3) |
1.907 |
0.011 |
0.0441 |
Cataract |
All phenotypes |
(GJB2, GJA8) |
1.034 |
0.00698 |
0.133 |
Cataract 1, multiple types (CTRCT1) [MIM:116200] |
(GJB2, GJA8) |
1.034 |
0.00698 |
0.00698 |
Cerebral amyloid angiopathy |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, PITRM1) |
5.675 |
1.25e-5 |
8.76e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, LCN2) |
5.144 |
3.75e-5 |
8.76e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(IGHG1, APP) |
5.144 |
3.75e-5 |
8.76e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, IDE) |
4.597 |
0.000116 |
0.000204 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(IGKC, APP) |
4.452 |
0.00303 |
0.00425 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, PSEN1) |
3.800 |
0.00736 |
0.00859 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, APP) |
1.323 |
0.0255 |
0.0255 |
Cerebrocostomandibular syndrome |
Cerebrocostomandibular syndrome (CCMS) [MIM:117650] |
(SNRPB, SF3A3) |
2.467 |
0.00107 |
0.00107 |
Charcot-Marie-Tooth disease |
All phenotypes |
(CRYAB, HSPB1) |
1.898 |
0.00879 |
0.229 |
Charcot-Marie-Tooth disease 2F (CMT2F) [MIM:606595] |
(CRYAB, HSPB1) |
1.898 |
0.00879 |
0.0615 |
Cherubism |
Cherubism (CRBM) [MIM:118400] |
(SH3BP2, TNKS2) |
3.492 |
4.38e-8 |
4.38e-8 |
Coagulation factor deficiency |
All phenotypes |
(F2, F5) |
3.075 |
0.0221 |
0.199 |
All phenotypes |
(F12, APP) |
2.001 |
0.0339 |
0.219 |
All phenotypes |
(F2, F2R) |
2.001 |
0.00399 |
0.108 |
All phenotypes |
(F2, SERPINC1) |
1.982 |
0.0126 |
0.171 |
All phenotypes |
(F2, SERPIND1) |
1.812 |
0.0464 |
0.219 |
All phenotypes |
(F2, GP1BA) |
1.786 |
0.0486 |
0.219 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, F5) |
3.075 |
0.0221 |
0.118 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, F2R) |
2.001 |
0.00399 |
0.0638 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, SERPINC1) |
1.982 |
0.0126 |
0.101 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, SERPIND1) |
1.812 |
0.0464 |
0.156 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, GP1BA) |
1.786 |
0.0486 |
0.156 |
Factor XII deficiency (FA12D) [MIM:234000] |
(F12, APP) |
2.001 |
0.0339 |
0.0339 |
Cockayne syndrome |
Cockayne syndrome A (CSA) [MIM:216400] |
(ERCC8, WDR61) |
3.342 |
0.0148 |
0.0148 |
Colorectal cancer |
All phenotypes |
(HLA-A, CTNNB1) |
5.072 |
0.0297 |
0.157 |
All phenotypes |
(BRAF, YWHAQ) |
3.361 |
0.00182 |
0.0257 |
All phenotypes |
(BRAF, YWHAG) |
3.274 |
0.00217 |
0.0257 |
All phenotypes |
(BRAF, YWHAZ) |
3.191 |
0.00256 |
0.0257 |
All phenotypes |
(BRAF, YWHAB) |
3.152 |
0.00277 |
0.0257 |
All phenotypes |
(BRAF, MAP2K1) |
2.776 |
0.00587 |
0.0434 |
All phenotypes |
(BRAF, MAP2K2) |
2.503 |
0.0101 |
0.062 |
All phenotypes |
(MLH1, PMS2) |
1.002 |
0.0462 |
0.201 |
Colorectal cancer (CRC) [MIM:114500] |
(HLA-A, CTNNB1) |
5.072 |
0.0297 |
0.0765 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAQ) |
3.361 |
0.00182 |
0.0125 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAG) |
3.274 |
0.00217 |
0.0125 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAZ) |
3.191 |
0.00256 |
0.0125 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAB) |
3.152 |
0.00277 |
0.0125 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, MAP2K1) |
2.776 |
0.00587 |
0.0211 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, MAP2K2) |
2.503 |
0.0101 |
0.0302 |
Cone-rod dystrophy |
All phenotypes |
(CRX, RHOXF2) |
2.528 |
0.03 |
0.16 |
All phenotypes |
(CRX, RAX2) |
2.322 |
0.04 |
0.16 |
Cone-rod dystrophy 2 (CORD2) [MIM:120970] |
(CRX, RHOXF2) |
2.528 |
0.03 |
0.06 |
Cone-rod dystrophy 2 (CORD2) [MIM:120970] |
(CRX, RAX2) |
2.322 |
0.04 |
0.06 |
Congenital heart defects |
All phenotypes |
(HERC2, CDC42) |
4.992 |
0.0314 |
0.267 |
All phenotypes |
(SMARCA4, CHD4) |
2.661 |
0.00824 |
0.267 |
Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159] |
(SMARCA4, CHD4) |
2.661 |
0.00824 |
0.00824 |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
(HERC2, CDC42) |
4.992 |
0.0314 |
0.266 |
Cortical dysplasia complex with other brain malformations |
All phenotypes |
(TUBB3, TUBA1A) |
1.661 |
0.0439 |
0.307 |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
(TUBB3, TUBA1A) |
1.661 |
0.0439 |
0.0878 |
Corticosterone methyloxidase deficiency |
All phenotypes |
(CYP11B2, CYP11B2) |
1.883 |
0.0362 |
0.0362 |
Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600] |
(CYP11B2, CYP11B2) |
2.146 |
0.0201 |
0.0201 |
Creutzfeldt-Jakob disease |
Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
(PRNP, PRNP) |
0.933 |
0.0108 |
0.0108 |
Crigler-Najjar syndrome |
All phenotypes |
(UGT1A1, UGT1A1) |
1.800 |
9.36e-5 |
0.00025 |
All phenotypes |
(UGT1A1, UGT1A10) |
1.800 |
9.36e-5 |
0.00025 |
All phenotypes |
(UGT1A1, UGT1A8) |
1.800 |
9.36e-5 |
0.00025 |
All phenotypes |
(UGT1A9, UGT1A1) |
1.713 |
0.000336 |
0.000423 |
All phenotypes |
(UGT1A1, UGT1A3) |
1.674 |
0.000423 |
0.000423 |
All phenotypes |
(UGT1A1, UGT1A4) |
1.674 |
0.000423 |
0.000423 |
All phenotypes |
(UGT1A1, UGT1A7) |
1.674 |
0.000423 |
0.000423 |
All phenotypes |
(UGT1A6, UGT1A1) |
1.674 |
0.000423 |
0.000423 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A1) |
2.144 |
0.000221 |
0.000589 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A10) |
2.144 |
0.000221 |
0.000589 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A8) |
2.144 |
0.000221 |
0.000589 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A9, UGT1A1) |
1.990 |
0.00118 |
0.00138 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A3) |
1.952 |
0.00138 |
0.00138 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A4) |
1.952 |
0.00138 |
0.00138 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A7) |
1.952 |
0.00138 |
0.00138 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A6, UGT1A1) |
1.952 |
0.00138 |
0.00138 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A9, UGT1A1) |
1.859 |
0.00215 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A1) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A10) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A3) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A4) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A7) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A8) |
1.821 |
0.0025 |
0.0025 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A6, UGT1A1) |
1.821 |
0.0025 |
0.0025 |
Cutis laxa |
All phenotypes |
(ATP6V1B2, ATP6V1E1) |
2.199 |
0.0474 |
0.166 |
All phenotypes |
(PYCR1, PYCR1) |
0.810 |
0.0459 |
0.166 |
Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402] |
(ATP6V1B2, ATP6V1E1) |
2.199 |
0.0474 |
0.0949 |
Deafness |
All phenotypes |
(CDC7, MCM2) |
6.785 |
0.00907 |
0.118 |
All phenotypes |
(AIFM1, AIFM1) |
3.804 |
0.00732 |
0.118 |
All phenotypes |
(KCNQ4, KCNQ4) |
1.124 |
0.0172 |
0.149 |
Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101] |
(KCNQ4, KCNQ4) |
1.124 |
0.0172 |
0.0172 |
Deafness, autosomal dominant, 70 (DFNA70) [MIM:616968] |
(CDC7, MCM2) |
6.785 |
0.00907 |
0.00907 |
Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614] |
(AIFM1, AIFM1) |
3.804 |
0.00732 |
0.00732 |
Dehydrated hereditary stomatocytosis 2 |
Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689] |
(KCNN4, KCNN4) |
1.523 |
0.0421 |
0.126 |
Dementia |
All phenotypes |
(MAPT, MAPT) |
0.794 |
0.0146 |
0.175 |
Frontotemporal dementia (FTD) [MIM:600274] |
(MAPT, MAPT) |
0.794 |
0.0146 |
0.0729 |
Diabetes mellitus |
All phenotypes |
(INSR, GRB10) |
2.340 |
0.0206 |
0.0687 |
All phenotypes |
(ABCC8, KCNJ11) |
2.215 |
1.92e-5 |
0.000384 |
All phenotypes |
(INS, INS) |
0.737 |
0.00135 |
0.0122 |
All phenotypes |
(KCNJ11, KCNJ11) |
0.674 |
0.00183 |
0.0122 |
All phenotypes |
(INS, INSR) |
0.671 |
0.0132 |
0.0527 |
All phenotypes |
(INS, IDE) |
0.664 |
0.00692 |
0.0346 |
Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853] |
(INSR, SH2B1) |
5.416 |
0.0232 |
0.031 |
Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853] |
(SH2B2, INSR) |
5.416 |
0.0232 |
0.031 |
Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853] |
(INSR, GRB10) |
4.694 |
0.00196 |
0.00783 |
Diabetes mellitus, permanent neonatal 2 (PNDM2) [MIM:618856] |
(KCNJ11, KCNJ11) |
0.657 |
0.00592 |
0.0118 |
Diabetes mellitus, permanent neonatal 3 (PNDM3) [MIM:618857] |
(ABCC8, KCNJ11) |
3.123 |
0.00021 |
0.00021 |
Diabetes mellitus, permanent neonatal 4 (PNDM4) [MIM:618858] |
(INS, INSR) |
0.764 |
0.00466 |
0.014 |
Diabetes mellitus, permanent neonatal 4 (PNDM4) [MIM:618858] |
(INS, IDE) |
0.758 |
0.00178 |
0.0102 |
Diabetes mellitus, permanent neonatal 4 (PNDM4) [MIM:618858] |
(INS, INS) |
0.731 |
0.00226 |
0.0102 |
Dihydrolipoamide dehydrogenase deficiency |
Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900] |
(DLD, DBT) |
3.006 |
0.0244 |
0.0366 |
Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900] |
(PDHX, DLD) |
2.421 |
0.0157 |
0.0366 |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(F2, FGB) |
6.143 |
0.0142 |
0.0752 |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(FGA, KLK6) |
5.541 |
0.0215 |
0.0752 |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(F2, FGA) |
4.389 |
0.0477 |
0.111 |
Dystonia |
All phenotypes |
(SPR, SPR) |
2.273 |
0.0428 |
0.385 |
Dystonia, DOPA-responsive, due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716] |
(SPR, SPR) |
2.273 |
0.0428 |
0.0428 |
Ectrodactyly-ectodermal dysplasia |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
(PPP1R13L, TP63) |
3.939 |
3.83e-14 |
7.66e-14 |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
(TP53BP2, TP63) |
3.746 |
2.1e-13 |
2.1e-13 |
Ehlers-Danlos syndrome |
All phenotypes |
(COL3A1, COL3A1) |
1.583 |
1.63e-9 |
3.26e-9 |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
(COL3A1, COL3A1) |
1.653 |
3.5e-10 |
7.01e-10 |
Elliptocytosis |
All phenotypes |
(SPTA1, SPTB) |
4.680 |
1.32e-19 |
3.97e-19 |
All phenotypes |
(SPTA1, SPTBN1) |
4.186 |
9.93e-15 |
1.49e-14 |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1, SPTB) |
5.117 |
2.74e-16 |
5.49e-16 |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1, SPTBN1) |
4.186 |
9.93e-15 |
9.93e-15 |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTA1, SPTB) |
4.203 |
2.43e-5 |
4.85e-5 |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTB, SPTAN1) |
3.407 |
0.000211 |
0.000211 |
Emery-Dreifuss muscular dystrophy |
All phenotypes |
(LMNA, MAPRE2) |
1.349 |
0.0126 |
0.0881 |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
(LMNA, MAPRE2) |
1.207 |
0.031 |
0.217 |
Epidermolysis bullosa |
All phenotypes |
(ITGB4, DST) |
2.480 |
0.0485 |
0.0707 |
All phenotypes |
(KRT14, KRT80) |
1.329 |
0.00211 |
0.00674 |
All phenotypes |
(KRT86, KRT14) |
1.329 |
0.00211 |
0.00674 |
All phenotypes |
(KRT14, KRT3) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, KRT6C) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, KRT72) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, KRT79) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, KRT81) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, PRPH) |
1.303 |
0.00242 |
0.00674 |
All phenotypes |
(KRT14, KRT78) |
1.251 |
0.00319 |
0.00796 |
All phenotypes |
(KRT14, KRT5) |
1.230 |
0.000243 |
0.00608 |
All phenotypes |
(KRT5, KRT24) |
1.225 |
0.0125 |
0.0283 |
All phenotypes |
(KRT38, KRT5) |
1.079 |
0.0399 |
0.0707 |
All phenotypes |
(KRT5, KRT15) |
1.053 |
0.0434 |
0.0707 |
All phenotypes |
(KRT5, KRT40) |
1.053 |
0.0434 |
0.0707 |
All phenotypes |
(KRT5, KRT35) |
1.027 |
0.047 |
0.0707 |
Epidermolysis bullosa letalis, with pyloric atresia (EB-PA) [MIM:226730] |
(ITGB4, DST) |
2.480 |
0.0485 |
0.104 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT80) |
1.597 |
0.00734 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT86, KRT14) |
1.597 |
0.00734 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT5) |
1.586 |
0.000668 |
0.0147 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT3) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT6C) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT72) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT79) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT81) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, PRPH) |
1.570 |
0.008 |
0.0196 |
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800] |
(KRT14, KRT78) |
1.519 |
0.00946 |
0.0208 |
Epidermolytic hyperkeratosis |
Epidermolytic hyperkeratosis (EHK) [MIM:113800] |
(KRT1, KRT33B) |
1.859 |
0.00159 |
0.0052 |
Epidermolytic hyperkeratosis (EHK) [MIM:113800] |
(KRT37, KRT1) |
1.835 |
0.00173 |
0.0052 |
Epidermolytic hyperkeratosis (EHK) [MIM:113800] |
(KRT1, KRT10) |
0.766 |
0.0143 |
0.0287 |
Epilepsy |
All phenotypes |
(SNAP23, STX1B) |
2.823 |
0.02 |
0.178 |
All phenotypes |
(STX1B, STX4) |
2.621 |
0.0264 |
0.178 |
All phenotypes |
(GABRG2, GABRB3) |
2.182 |
0.0107 |
0.178 |
All phenotypes |
(GABRG2, GABRB2) |
1.930 |
0.0181 |
0.178 |
All phenotypes |
(CHRNB2, CHRNA4) |
1.229 |
0.0331 |
0.179 |
Generalized epilepsy with febrile seizures plus 3 (GEFS+3) [MIM:607681] |
(GABRG2, GABRB3) |
2.182 |
0.0485 |
0.0688 |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
(SNAP23, STX1B) |
2.823 |
0.02 |
0.0528 |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
(STX1B, STX4) |
2.621 |
0.0264 |
0.0528 |
Epileptic encephalopathy |
All phenotypes |
(USP8, YWHAG) |
2.874 |
0.0186 |
0.319 |
All phenotypes |
(YWHAG, BAIAP2) |
2.364 |
0.0377 |
0.329 |
All phenotypes |
(GABRG2, GABRB2) |
1.398 |
0.0184 |
0.319 |
All phenotypes |
(KCNB1, KCNV2) |
1.229 |
0.024 |
0.319 |
All phenotypes |
(HCN1, HCN1) |
1.126 |
0.0157 |
0.319 |
All phenotypes |
(CDKL5, PRKG2) |
1.084 |
0.0489 |
0.337 |
All phenotypes |
(KCNQ2, KCNQ2) |
0.844 |
0.0313 |
0.319 |
All phenotypes |
(GABRA1, GABRB3) |
0.790 |
0.0275 |
0.319 |
Epileptic encephalopathy, early infantile, 24 (EIEE24) [MIM:615871] |
(HCN1, HCN1) |
1.126 |
0.0157 |
0.0315 |
Epileptic encephalopathy, early infantile, 26 (EIEE26) [MIM:616056] |
(KCNB1, KCNV2) |
1.229 |
0.024 |
0.118 |
Epileptic encephalopathy, early infantile, 2 (EIEE2) [MIM:300672] |
(CDKL5, PRKG2) |
1.084 |
0.0489 |
0.0489 |
Epileptic encephalopathy, early infantile, 56 (EIEE56) [MIM:617665] |
(USP8, YWHAG) |
2.874 |
0.0186 |
0.242 |
Epileptic encephalopathy, early infantile, 56 (EIEE56) [MIM:617665] |
(YWHAG, BAIAP2) |
2.364 |
0.0377 |
0.245 |
Epileptic encephalopathy, early infantile, 74 (EIEE74) [MIM:618396] |
(GABRG2, GABRB3) |
1.598 |
0.024 |
0.0668 |
Epileptic encephalopathy, early infantile, 74 (EIEE74) [MIM:618396] |
(GABRG2, GABRB2) |
1.345 |
0.0445 |
0.0668 |
Epileptic encephalopathy, early infantile, 7 (EIEE7) [MIM:613720] |
(KCNQ2, KCNQ2) |
0.844 |
0.0313 |
0.094 |
Erythrocytosis |
All phenotypes |
(VHL, EPAS1) |
4.233 |
2.24e-5 |
0.000157 |
All phenotypes |
(EPAS1, EGLN1) |
3.725 |
0.000127 |
0.000443 |
All phenotypes |
(EGLN2, EPAS1) |
3.680 |
0.00946 |
0.0221 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EPAS1, EGLN1) |
4.265 |
0.000332 |
0.000497 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(VHL, EPAS1) |
4.233 |
2.24e-5 |
6.72e-5 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EGLN2, EPAS1) |
3.680 |
0.00946 |
0.00946 |
Esophageal cancer |
Esophageal cancer (ESCR) [MIM:133239] |
(PDGFRA, TGFBR2) |
4.558 |
0.0425 |
0.0425 |
Exudative vitreoretinopathy |
All phenotypes |
(NDP, FZD4) |
1.201 |
0.00495 |
0.00989 |
Fabry disease |
Fabry disease (FD) [MIM:301500] |
(GLA, GLA) |
0.700 |
0.00953 |
0.00953 |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASA1) |
1.833 |
9.53e-5 |
0.000763 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RIN1) |
1.686 |
0.00216 |
0.00432 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASGRF1) |
1.645 |
0.000278 |
0.000802 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, NF1) |
1.418 |
0.0141 |
0.0141 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASGRP4) |
1.373 |
0.00339 |
0.00527 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RGL1) |
1.341 |
0.00395 |
0.00527 |
Costello syndrome (CSTLO) [MIM:218040] |
(RGL2, HRAS) |
1.218 |
0.00701 |
0.00801 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, SOS1) |
0.975 |
0.000301 |
0.000802 |
Fanconi anemia |
All phenotypes |
(BRCA1, ATRIP) |
4.723 |
0.0379 |
0.177 |
All phenotypes |
(BRCA1, BRAT1) |
4.723 |
0.0379 |
0.177 |
All phenotypes |
(BRCA2, SEM1) |
3.020 |
0.0152 |
0.177 |
Fanconi anemia complementation group D1 (FANCD1) [MIM:605724] |
(BRCA2, SEM1) |
3.020 |
0.0152 |
0.0152 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
(BRCA1, ATRIP) |
4.723 |
0.0379 |
0.0946 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
(BRCA1, BRAT1) |
4.723 |
0.0379 |
0.0946 |
Fibrodysplasia ossificans progressiva |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
(FKBP1B, ACVR1) |
2.629 |
0.00989 |
0.0396 |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
(FKBP1A, ACVR1) |
2.093 |
0.0271 |
0.0542 |
Fibrosis of extraocular muscles |
All phenotypes |
(KIF21A, KIF21A) |
3.776 |
9.0e-9 |
1.8e-8 |
Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700] |
(KIF21A, KIF21A) |
3.776 |
9.0e-9 |
9.0e-9 |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
(MAPT, TUBB3) |
3.578 |
0.0113 |
0.0113 |
Focal segmental glomerulosclerosis |
All phenotypes |
(ACTN4, IQGAP1) |
4.755 |
0.000142 |
0.000712 |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
(ACTN4, IQGAP1) |
4.755 |
0.000142 |
0.00057 |
Frontometaphyseal dysplasia |
Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137] |
(MAP3K7, TNIK) |
2.262 |
0.00906 |
0.0272 |
Galactosemia 1 |
All phenotypes |
(GALT, GALT) |
0.330 |
0.0306 |
0.0613 |
Galactosemia 1 (GALAC1) [MIM:230400] |
(GALT, GALT) |
0.330 |
0.0306 |
0.0306 |
Gastric cancer |
All phenotypes |
(HLA-A, KRAS) |
3.954 |
2.57e-6 |
2.06e-5 |
All phenotypes |
(HLA-Cw, KRAS) |
3.632 |
0.000115 |
0.000306 |
All phenotypes |
(KRAS, HLA-C) |
3.632 |
0.000115 |
0.000306 |
All phenotypes |
(KRAS, NF1) |
1.784 |
0.0151 |
0.0241 |
All phenotypes |
(KRAS, SOS1) |
1.495 |
0.002 |
0.00399 |
Gastric cancer (GASC) [MIM:613659] |
(HLA-A, KRAS) |
3.954 |
2.57e-6 |
1.54e-5 |
Gastric cancer (GASC) [MIM:613659] |
(HLA-Cw, KRAS) |
3.632 |
0.000115 |
0.00023 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, HLA-C) |
3.632 |
0.000115 |
0.00023 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, NF1) |
1.784 |
0.0151 |
0.0181 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, SOS1) |
1.495 |
0.002 |
0.00299 |
Glanzmann thrombasthenia |
Glanzmann thrombasthenia (GT) [MIM:273800] |
(FGG, ITGB3) |
3.546 |
0.000365 |
0.00292 |
Glanzmann thrombasthenia (GT) [MIM:273800] |
(FN1, ITGB3) |
2.131 |
0.0125 |
0.0498 |
Glioma |
Glioma (GLM) [MIM:137800] |
(H3-3A, SETD2) |
2.791 |
0.026 |
0.198 |
Glutaric aciduria |
All phenotypes |
(ETFA, ETFB) |
1.299 |
0.0413 |
0.165 |
Growth hormone deficiency |
All phenotypes |
(HTR2C, GHSR) |
2.860 |
0.019 |
0.133 |
Growth hormone deficiency, isolated partial (GHDP) [MIM:615925] |
(HTR2C, GHSR) |
2.860 |
0.019 |
0.0759 |
Growth hormone insensitivity |
All phenotypes |
(JAK1, STAT5B) |
4.717 |
0.0377 |
0.0753 |
Growth hormone insensitivity with immunodeficiency (GHII) [MIM:245590] |
(JAK1, STAT5B) |
4.717 |
0.0377 |
0.0377 |
Growth retardation |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2A1, CDK11A) |
2.597 |
0.00692 |
0.0346 |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2B, CSNK2A1) |
2.535 |
0.0397 |
0.0992 |
Hemochromatosis |
All phenotypes |
(HAMP, SLC40A1) |
1.624 |
0.00748 |
0.0524 |
Hemochromatosis 4 (HFE4) [MIM:606069] |
(HAMP, SLC40A1) |
2.160 |
0.00272 |
0.00272 |
Hemolytic anemia |
All phenotypes |
(PKLR, PKLR) |
0.423 |
0.0362 |
0.145 |
Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
(PKLR, PKLR) |
0.423 |
0.0362 |
0.0362 |
Hemolytic uremic syndrome |
All phenotypes |
(C3, CFHR4) |
3.604 |
0.00021 |
0.00105 |
All phenotypes |
(C3, CR2) |
3.452 |
0.000314 |
0.00105 |
All phenotypes |
(C3, CD46) |
2.435 |
0.0165 |
0.0412 |
All phenotypes |
(C3, CFH) |
1.590 |
0.000105 |
0.00105 |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
(C3, CFHR4) |
3.604 |
0.00021 |
0.000629 |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
(C3, CR2) |
3.452 |
0.000314 |
0.000629 |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
(C3, CD46) |
3.001 |
0.0246 |
0.0369 |
Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925] |
(C3, CFH) |
2.551 |
0.000168 |
0.000629 |
Hemophilia |
All phenotypes |
(F9, SERPINC1) |
0.641 |
0.0302 |
0.0907 |
All phenotypes |
(F8, F8) |
0.459 |
0.00241 |
0.0144 |
Hemophilia A (HEMA) [MIM:306700] |
(F8, F8) |
0.459 |
0.00241 |
0.00962 |
Hemophilia B (HEMB) [MIM:306900] |
(F9, SERPINC1) |
0.641 |
0.0302 |
0.0604 |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(PIK3CA, GRB2) |
6.352 |
0.0122 |
0.0765 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, GRB14) |
4.519 |
0.00249 |
0.0311 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, GRB7) |
4.519 |
0.00249 |
0.0311 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, KDR) |
3.426 |
0.0111 |
0.0765 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, BTK) |
2.872 |
0.0234 |
0.117 |
Hirschsprung disease |
All phenotypes |
(RET, GRB10) |
1.793 |
0.00394 |
0.063 |
All phenotypes |
(RET, RET) |
0.860 |
0.0361 |
0.289 |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET, GRB10) |
1.793 |
0.00394 |
0.059 |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET, RET) |
0.860 |
0.0361 |
0.27 |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
(BANF1, LMNA) |
3.314 |
0.016 |
0.064 |
Hypercholesterolemia |
All phenotypes |
(, PCSK9) |
2.637 |
0.0101 |
0.0506 |
All phenotypes |
(LDLR, APOH) |
1.520 |
0.0312 |
0.0634 |
All phenotypes |
(LDLR, PCSK9) |
1.162 |
0.0381 |
0.0634 |
Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890] |
(LDLR, APOH) |
1.520 |
0.0312 |
0.125 |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(LDLR, PCSK9) |
2.927 |
0.0268 |
0.0268 |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(, PCSK9) |
2.637 |
0.0101 |
0.0202 |
Hyperekplexia |
Hyperekplexia 1 (HKPX1) [MIM:149400] |
(GLRA1, GLRA1) |
1.322 |
6.22e-5 |
6.22e-5 |
Hyperimmunoglobulin E recurrent infection syndrome |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060] |
(STAT3, STAT3) |
1.483 |
0.0473 |
0.289 |
Hyperinsulinemic hypoglycemia |
All phenotypes |
(INSR, GRB7) |
5.369 |
0.0242 |
0.0664 |
All phenotypes |
(INSR, GRB10) |
5.279 |
0.0258 |
0.0664 |
All phenotypes |
(INSR, IRS1) |
5.279 |
0.0258 |
0.0664 |
All phenotypes |
(INSR, GRB14) |
5.236 |
0.0265 |
0.0664 |
Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968] |
(INSR, GRB7) |
5.369 |
0.0242 |
0.0265 |
Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968] |
(INSR, GRB10) |
5.279 |
0.0258 |
0.0265 |
Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968] |
(INSR, IRS1) |
5.279 |
0.0258 |
0.0265 |
Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968] |
(INSR, GRB14) |
5.236 |
0.0265 |
0.0265 |
Leucine-induced hypoglycemia (LIH) [MIM:240800] |
(ABCC8, KCNJ11) |
5.123 |
0.0287 |
0.0287 |
Hyperlipoproteinemia |
All phenotypes |
(APOE, BCL2) |
2.576 |
1.82e-5 |
5.45e-5 |
Hyperlipoproteinemia 3 (HLPP3) [MIM:617347] |
(APOE, BCL2) |
2.576 |
1.82e-5 |
3.63e-5 |
Hypocalcemia |
All phenotypes |
(KCNJ5, KCNJ15) |
1.101 |
0.022 |
0.044 |
All phenotypes |
(CASR, CASR) |
0.855 |
0.00663 |
0.0265 |
Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677] |
(KCNJ5, KCNJ15) |
1.101 |
0.022 |
0.022 |
Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198] |
(CASR, CASR) |
0.855 |
0.00663 |
0.00663 |
Hypocalciuric hypercalcemia |
Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980] |
(CASR, CASR) |
0.502 |
0.0471 |
0.0471 |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281] |
(DARS1, DARS1) |
1.469 |
0.0148 |
0.0148 |
Hypophosphatemic nephrolithiasis/osteoporosis |
Osteoporosis (OSTEOP) [MIM:166710] |
(WNT1, WLS) |
2.356 |
0.0382 |
0.0382 |
Ichthyosis |
All phenotypes |
(ABCA1, ABCA12) |
2.503 |
0.0443 |
0.362 |
All phenotypes |
(KRT2, KRT27) |
0.641 |
0.0495 |
0.362 |
All phenotypes |
(KRT2, KRT33B) |
0.641 |
0.0495 |
0.362 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT27) |
0.641 |
0.0495 |
0.297 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT33B) |
0.641 |
0.0495 |
0.297 |
Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277] |
(ABCA1, ABCA12) |
2.503 |
0.0443 |
0.0443 |
Imagawa-Matsumoto syndrome |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12, EZH2) |
2.513 |
0.00537 |
0.00576 |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12, EZH1) |
2.480 |
0.00576 |
0.00576 |
Immunodeficiency |
All phenotypes |
(UBC, IKBKG) |
2.742 |
0.0278 |
0.64 |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
(STAT1, STAT1) |
1.734 |
0.044 |
0.176 |
Immunodeficiency 33 (IMD33) [MIM:300636] |
(UBC, IKBKG) |
2.742 |
0.0278 |
0.0835 |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790] |
(FOXP3, FOXP3) |
0.830 |
0.0423 |
0.0847 |
Inclusion body myopathy |
All phenotypes |
(VCP, VCP) |
0.726 |
0.0442 |
0.308 |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320] |
(VCP, VCP) |
0.726 |
0.0442 |
0.132 |
Incontinentia pigmenti |
Incontinentia pigmenti (IP) [MIM:308300] |
(UBC, IKBKG) |
2.104 |
0.0255 |
0.127 |
Intellectual developmental disorder |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
(TRIO, RAC1) |
4.724 |
0.00143 |
0.00143 |
Intellectual developmental disorder with hypotonia and behavioral abnormalities |
Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748] |
(BUB1, CDK8) |
1.841 |
0.0429 |
0.111 |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
(FGF1, FGFR1) |
4.347 |
0.0492 |
0.161 |
Jervell and Lange-Nielsen syndrome |
All phenotypes |
(KCNE1, KCNQ1) |
2.247 |
0.0221 |
0.0662 |
Juvenile polyposis |
All phenotypes |
(BMPR1A, BMPR1A) |
2.944 |
0.0259 |
0.189 |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
(BMPR1A, BMPR1A) |
2.944 |
0.0259 |
0.107 |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, RIN1) |
2.455 |
0.00606 |
0.0825 |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, RASA1) |
2.200 |
0.0103 |
0.0825 |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, RGL3) |
1.886 |
0.0198 |
0.106 |
Keratitis-ichthyosis-deafness syndrome |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB2, GJA5) |
1.792 |
0.034 |
0.0469 |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB1, GJB2) |
1.422 |
0.0194 |
0.0469 |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB2, GJA8) |
1.162 |
0.0399 |
0.0469 |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB2, GJB2) |
1.103 |
0.0469 |
0.0469 |
Keratoendothelitis fugax hereditaria |
Keratoendothelitis fugax hereditaria (KEFH) [MIM:148200] |
(NLRP3, PYCARD) |
5.982 |
0.0158 |
0.0316 |
Keratoendothelitis fugax hereditaria (KEFH) [MIM:148200] |
(NLRP3, NLRP3) |
4.363 |
0.0486 |
0.0486 |
Keratosis |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3CA, GRB2) |
6.352 |
0.00015 |
0.0015 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3CA, PIK3R3) |
3.030 |
0.015 |
0.0486 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3R1, PIK3CA) |
2.843 |
0.0194 |
0.0486 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(FGFR3, FGFR3) |
1.970 |
0.011 |
0.0486 |
Leber congenital amaurosis |
All phenotypes |
(DAPK1, TUBB4B) |
4.752 |
0.00138 |
0.00413 |
Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879] |
(DAPK1, TUBB4B) |
4.752 |
0.00138 |
0.00138 |
Leber optic neuropathy |
All phenotypes |
(MT-ND1, MT-ND6) |
2.203 |
0.00143 |
0.01 |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
(MT-ND1, MT-ND6) |
1.951 |
0.0292 |
0.175 |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
(MT-ND1, MT-ND6) |
2.688 |
0.0241 |
0.0482 |
Leopard syndrome |
All phenotypes |
(ERBB2, PTPN11) |
2.739 |
0.00202 |
0.0121 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(ERBB2, PTPN11) |
2.739 |
0.00202 |
0.00202 |
Leukemia |
All phenotypes |
(MET, PTPN11) |
4.601 |
5.4e-8 |
8.1e-7 |
All phenotypes |
(HLA-A, KRAS) |
4.217 |
0.000155 |
0.000583 |
All phenotypes |
(HLA-Cw, KRAS) |
4.217 |
0.000155 |
0.000583 |
All phenotypes |
(KRAS, HLA-C) |
4.217 |
0.000155 |
0.000583 |
All phenotypes |
(HLA-Cw, NRAS) |
4.087 |
0.00346 |
0.0104 |
All phenotypes |
(DNMT3A, DNMT3A) |
3.284 |
0.0105 |
0.0198 |
All phenotypes |
(KRAS, NF1) |
2.369 |
0.00725 |
0.0155 |
All phenotypes |
(NRAS, RASA1) |
2.200 |
0.0474 |
0.0646 |
All phenotypes |
(ERBB2, PTPN11) |
2.186 |
0.0247 |
0.0411 |
All phenotypes |
(GRB2, PTPN11) |
2.041 |
0.00428 |
0.0107 |
All phenotypes |
(KRAS, SOS1) |
1.495 |
0.0447 |
0.0646 |
Leukemia, acute myelogenous (AML) [MIM:601626] |
(DNMT3A, DNMT3A) |
3.284 |
0.0105 |
0.0105 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(MET, PTPN11) |
4.601 |
5.4e-8 |
7.56e-7 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-A, KRAS) |
4.217 |
0.000155 |
0.000544 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-Cw, KRAS) |
4.217 |
0.000155 |
0.000544 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, HLA-C) |
4.217 |
0.000155 |
0.000544 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-Cw, NRAS) |
4.087 |
0.00346 |
0.00969 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, NF1) |
2.369 |
0.00725 |
0.0145 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(NRAS, RASA1) |
2.200 |
0.0474 |
0.0663 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(ERBB2, PTPN11) |
2.186 |
0.0247 |
0.0432 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(GRB2, PTPN11) |
2.041 |
0.00428 |
0.00999 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, SOS1) |
1.495 |
0.0447 |
0.0663 |
Leukodystrophy hypomyelinating |
All phenotypes |
(POLR3A, POLR1C) |
2.557 |
0.014 |
0.308 |
Leukodystrophy with vanishing white matter |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
(EIF2B5, EIF2B4) |
2.296 |
0.00328 |
0.00983 |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
(EIF2B5, EIF2B1) |
2.144 |
0.0298 |
0.0596 |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
(EIF2B2, EIF2B5) |
2.071 |
2.4e-5 |
0.000144 |
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation |
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
(DARS2, DARS2) |
1.687 |
0.000571 |
0.00114 |
Li-Fraumeni syndrome |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(HLA-A, TP53) |
1.581 |
0.0154 |
0.0733 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, HLA-A) |
1.581 |
0.0154 |
0.0733 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, TP53BP2) |
1.581 |
0.000635 |
0.00953 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, BCL2L1) |
0.944 |
0.0211 |
0.0733 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, BCL2) |
0.925 |
0.0293 |
0.0733 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, TP53BP1) |
0.803 |
0.0275 |
0.0733 |
Limb-girdle muscular dystrophy |
All phenotypes |
(SMCHD1, SMCHD1) |
1.626 |
0.0147 |
0.133 |
Facioscapulohumeral muscular dystrophy 2 (FSHD2) [MIM:158901] |
(SMCHD1, SMCHD1) |
1.626 |
0.0147 |
0.0147 |
Lipodystrophy |
All phenotypes |
(LMNA, MAPRE2) |
2.091 |
0.0302 |
0.362 |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
(LMNA, MAPRE2) |
2.091 |
0.0302 |
0.181 |
Lissencephaly |
All phenotypes |
(MAPT, TUBA1A) |
3.798 |
6.27e-7 |
4.39e-6 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(MAPT, TUBA1A) |
3.798 |
6.27e-7 |
1.88e-6 |
Lissencephaly with microcephaly |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
(KATNA1, KATNB1) |
2.473 |
0.0324 |
0.0342 |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
(KATNB1, KATNAL1) |
2.436 |
0.0342 |
0.0342 |
Loeys-Dietz syndrome |
All phenotypes |
(SMAD3, SMAD4) |
1.957 |
0.0289 |
0.22 |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
(SMAD3, SMAD4) |
1.957 |
0.0289 |
0.0866 |
Long QT syndrome |
All phenotypes |
(KCNJ18, KCNJ2) |
1.093 |
0.000511 |
0.0143 |
All phenotypes |
(KCNJ2, KCNJ15) |
1.093 |
0.000511 |
0.0143 |
All phenotypes |
(CALM1, KCNQ4) |
0.952 |
0.0369 |
0.516 |
All phenotypes |
(KCNQ1, KCNQ1) |
0.340 |
0.00417 |
0.0778 |
Long QT syndrome 14 (LQT14) [MIM:616247] |
(CALM1, KCNQ4) |
0.952 |
0.0369 |
0.999 |
Long QT syndrome 1 (LQT1) [MIM:192500] |
(KCNQ1, KCNQ1) |
0.340 |
0.00417 |
0.0208 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ18, KCNJ2) |
1.093 |
0.000511 |
0.000767 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ2, KCNJ15) |
1.093 |
0.000511 |
0.000767 |
Lung cancer |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, PAK2) |
3.706 |
0.00587 |
0.0411 |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, MAPKAPK3) |
3.032 |
0.0149 |
0.0451 |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, AKT1) |
2.776 |
0.0213 |
0.0451 |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, MAPK3) |
2.639 |
0.0258 |
0.0451 |
Mandibuloacral dysplasia |
All phenotypes |
(BANF1, LMNA) |
4.314 |
0.0497 |
0.0993 |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
(BANF1, LMNA) |
4.314 |
0.0497 |
0.0497 |
Maple syrup urine disease |
All phenotypes |
(BCKDHB, BCKDHB) |
1.861 |
0.0346 |
0.104 |
Maple syrup urine disease 1B (MSUD1B) [MIM:248600] |
(BCKDHB, BCKDHB) |
1.861 |
0.0346 |
0.0693 |
Mastocytosis, cutaneous |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, NCK1) |
6.693 |
2.02e-10 |
2.63e-9 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, GRB2) |
6.593 |
3.37e-8 |
1.46e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, STAP1) |
6.178 |
1.06e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(NCK2, KIT) |
6.178 |
1.06e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(BCAR3, KIT) |
6.008 |
1.7e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(GRAP2, KIT) |
6.008 |
1.7e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, RASA1) |
6.008 |
1.7e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, VAV3) |
6.008 |
1.7e-7 |
2.45e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, SLA2) |
5.800 |
4.44e-9 |
2.89e-8 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, SH2B3) |
5.719 |
3.77e-7 |
4.91e-7 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, GRB2) |
7.178 |
4.77e-5 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, NCK1) |
6.956 |
6.49e-5 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, STAP1) |
6.763 |
8.48e-5 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(NCK2, KIT) |
6.763 |
8.48e-5 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(BCAR3, KIT) |
6.593 |
0.000107 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(GRAP2, KIT) |
6.593 |
0.000107 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, RASA1) |
6.593 |
0.000107 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, VAV3) |
6.593 |
0.000107 |
0.000134 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, SH2B3) |
6.304 |
0.00016 |
0.000178 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, SLA2) |
6.063 |
0.000224 |
0.000224 |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNB1, GNAS) |
2.217 |
0.00994 |
0.0199 |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNAS, GNAS) |
1.710 |
0.0286 |
0.0286 |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, GDNF) |
3.452 |
0.000434 |
0.00337 |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, ARTN) |
3.282 |
0.000674 |
0.00337 |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, NRTN) |
2.808 |
0.00226 |
0.00754 |
Medulloblastoma |
Medulloblastoma (MDB) [MIM:155255] |
(HLA-A, CTNNB1) |
5.072 |
0.000884 |
0.00354 |
Medulloblastoma (MDB) [MIM:155255] |
(CTNNB1, BTRC) |
4.860 |
0.0341 |
0.0683 |
Megalencephalic leukoencephalopathy |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779] |
(HTRA4, HTRA1) |
1.813 |
0.019 |
0.038 |
Melanoma |
All phenotypes |
(CDK4, CDKN1A) |
3.189 |
0.0152 |
0.0587 |
All phenotypes |
(CDK4, CDKN2C) |
3.125 |
0.0166 |
0.0587 |
All phenotypes |
(CDK4, CDKN1B) |
3.064 |
0.0181 |
0.0587 |
All phenotypes |
(CDK4, CDKN2D) |
2.649 |
0.0315 |
0.0819 |
All phenotypes |
(CDK4, CDKN2B) |
2.327 |
0.0483 |
0.0897 |
All phenotypes |
(CDKN2A, ANKRA2) |
0.986 |
0.0426 |
0.0897 |
All phenotypes |
(CDK4, CDKN2A) |
0.862 |
0.018 |
0.0587 |
Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601] |
(CDKN2A, ANKRA2) |
0.986 |
0.0426 |
0.128 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN1A) |
3.189 |
0.0152 |
0.0602 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2C) |
3.125 |
0.0166 |
0.0602 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN1B) |
3.064 |
0.0181 |
0.0602 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2D) |
2.649 |
0.0315 |
0.0788 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2B) |
2.327 |
0.0483 |
0.0964 |
Melanosis, neurocutaneous |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, HLA-A) |
4.087 |
0.00346 |
0.0138 |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, RIN1) |
2.455 |
0.0333 |
0.0632 |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, RASA1) |
2.200 |
0.0474 |
0.0632 |
Mental retardation |
All phenotypes |
(PPP2R1A, PPP2R5C) |
3.392 |
0.0128 |
0.103 |
All phenotypes |
(CAMK2B, CAMK2N2) |
3.068 |
0.0037 |
0.0353 |
All phenotypes |
(PPP2R1A, PPP2R5B) |
3.057 |
0.00273 |
0.0287 |
All phenotypes |
(PPP2R1A, CDC6) |
2.676 |
0.033 |
0.195 |
All phenotypes |
(PPP2R1A, PPP2R3B) |
2.676 |
0.033 |
0.195 |
All phenotypes |
(PPP2R1A, PPP2R5D) |
2.585 |
0.0372 |
0.195 |
All phenotypes |
(PPP2R1A, PPP2R2A) |
2.556 |
0.0386 |
0.195 |
All phenotypes |
(GNAI2, GNB1) |
2.522 |
1.0e-6 |
7.24e-5 |
All phenotypes |
(PPP2R1A, PPP2R2B) |
2.472 |
0.0431 |
0.195 |
All phenotypes |
(PPP2R1A, PPP2R5E) |
2.472 |
0.0431 |
0.195 |
All phenotypes |
(GNA11, GNB1) |
2.409 |
2.07e-6 |
7.24e-5 |
All phenotypes |
(GNAI1, GNB1) |
2.409 |
2.07e-6 |
7.24e-5 |
All phenotypes |
(GNAO1, GNB1) |
2.272 |
4.99e-6 |
0.000131 |
All phenotypes |
(RAC1, NGEF) |
2.061 |
0.026 |
0.195 |
All phenotypes |
(GNB1, GNAS) |
2.025 |
8.36e-5 |
0.0011 |
All phenotypes |
(RAC1, PKN1) |
1.941 |
0.0325 |
0.195 |
All phenotypes |
(GRK2, GNB1) |
1.918 |
0.000448 |
0.00523 |
All phenotypes |
(SMS, SMS) |
1.902 |
0.0087 |
0.0762 |
All phenotypes |
(KALRN, RAC1) |
1.885 |
0.0361 |
0.195 |
All phenotypes |
(TRIO, RAC1) |
1.830 |
0.0399 |
0.195 |
All phenotypes |
(RAD21, STAG1) |
1.794 |
0.0467 |
0.195 |
All phenotypes |
(GNB1, GNAS) |
1.740 |
4.34e-5 |
0.00076 |
All phenotypes |
(RAC1, ARHGEF19) |
1.727 |
0.0482 |
0.195 |
All phenotypes |
(VAV1, RAC1) |
1.727 |
0.0482 |
0.195 |
All phenotypes |
(GNB1, GNAI1) |
1.691 |
1.72e-5 |
0.000361 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R5C) |
3.392 |
0.0128 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R5B) |
3.057 |
0.00273 |
0.0273 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, CDC6) |
2.676 |
0.033 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R3B) |
2.676 |
0.033 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R5D) |
2.585 |
0.0372 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R2A) |
2.556 |
0.0386 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R2B) |
2.472 |
0.0431 |
0.0539 |
Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362] |
(PPP2R1A, PPP2R5E) |
2.472 |
0.0431 |
0.0539 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAI2, GNB1) |
2.522 |
1.0e-6 |
1.86e-5 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNA11, GNB1) |
2.409 |
2.07e-6 |
1.86e-5 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAI1, GNB1) |
2.409 |
2.07e-6 |
1.86e-5 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAO1, GNB1) |
2.272 |
4.99e-6 |
3.37e-5 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAS) |
2.025 |
8.36e-5 |
0.000282 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GRK2, GNB1) |
1.918 |
0.000448 |
0.00134 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAS) |
1.740 |
4.34e-5 |
0.000195 |
Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAI1) |
1.691 |
1.72e-5 |
9.29e-5 |
Mental retardation, autosomal dominant 47 (MRD47) [MIM:617635] |
(RAD21, STAG1) |
1.794 |
0.0467 |
0.0467 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, NGEF) |
2.061 |
0.026 |
0.183 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, PKN1) |
1.941 |
0.0325 |
0.183 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(KALRN, RAC1) |
1.885 |
0.0361 |
0.183 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(TRIO, RAC1) |
1.830 |
0.0399 |
0.183 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, ARHGEF19) |
1.727 |
0.0482 |
0.183 |
Mental retardation, autosomal dominant 48 (MRD48) [MIM:617751] |
(VAV1, RAC1) |
1.727 |
0.0482 |
0.183 |
Mental retardation, autosomal dominant 54 (MRD54) [MIM:617799] |
(CAMK2B, CAMK2N2) |
3.068 |
0.0037 |
0.0074 |
X-linked syndromic mental retardation Snyder-Robinson type (MRXSSR) [MIM:309583] |
(SMS, SMS) |
1.902 |
0.0087 |
0.0087 |
Metatropic dysplasia |
Metatropic dysplasia (MTD) [MIM:156530] |
(TRPV4, TRPV4) |
1.446 |
0.000311 |
0.000311 |
Mirror movements |
Mirror movements 1 (MRMV1) [MIM:157600] |
(DCC, NTN4) |
5.125 |
0.000821 |
0.00164 |
Mitochondrial DNA depletion syndrome |
All phenotypes |
(SUCLG1, SUCLA2) |
2.510 |
0.0379 |
0.152 |
Mitochondrial DNA depletion syndrome 5 (MTDPS5) [MIM:612073] |
(SUCLG1, SUCLA2) |
2.510 |
0.0379 |
0.0379 |
Mitochondrial complex deficiency |
All phenotypes |
(MT-ND6, NDUFA9) |
5.812 |
0.0177 |
0.4 |
All phenotypes |
(NDUFS8, NDUFS1) |
4.617 |
0.0403 |
0.4 |
All phenotypes |
(UQCRC2, UQCRC2) |
4.463 |
0.0453 |
0.4 |
All phenotypes |
(MT-ND3, NDUFA9) |
2.676 |
0.0304 |
0.4 |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
(MT-ND3, NDUFA9) |
2.676 |
0.0304 |
0.152 |
Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247] |
(MT-ND6, NDUFA9) |
5.812 |
0.0177 |
0.0177 |
Mitochondrial complex I deficiency, nuclear type 5 (MC1DN5) [MIM:618226] |
(NDUFS8, NDUFS1) |
4.617 |
0.0403 |
0.0743 |
Mitochondrial complex III deficiency, nuclear 5 (MC3DN5) [MIM:615160] |
(UQCRC2, UQCRC2) |
4.463 |
0.0453 |
0.0453 |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT31) |
1.902 |
0.000367 |
0.0034 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT34) |
1.877 |
0.000408 |
0.0034 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT37) |
1.877 |
0.000408 |
0.0034 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT33B) |
1.852 |
0.000452 |
0.0034 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT35) |
1.828 |
0.0005 |
0.0034 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT39) |
1.395 |
0.0395 |
0.132 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT14) |
1.368 |
0.0421 |
0.132 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT15) |
1.368 |
0.0421 |
0.132 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT16) |
1.368 |
0.0421 |
0.132 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT36) |
1.368 |
0.0421 |
0.132 |
Mullegama-Klein-Martinez syndrome |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
(CTCF, STAG2) |
4.576 |
0.0414 |
0.0827 |
Multiple neoplasia |
All phenotypes |
(RET, GDNF) |
3.905 |
2.18e-6 |
2.57e-5 |
All phenotypes |
(RET, ARTN) |
3.735 |
4.28e-6 |
2.57e-5 |
All phenotypes |
(RET, NRTN) |
3.261 |
2.74e-5 |
0.00011 |
All phenotypes |
(MEN1, JUND) |
1.184 |
0.00448 |
0.0134 |
All phenotypes |
(MEN1, KMT2A) |
0.523 |
0.0455 |
0.109 |
Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
(MEN1, JUND) |
1.184 |
0.00448 |
0.0179 |
Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
(MEN1, KMT2A) |
0.523 |
0.0455 |
0.0911 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, GDNF) |
4.107 |
8.75e-7 |
6.05e-6 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, ARTN) |
3.937 |
1.73e-6 |
6.05e-6 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, NRTN) |
3.463 |
1.13e-5 |
2.64e-5 |
Multiple self-healing squamous epithelioma |
Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
(TGFBR1, TGFBR2) |
3.184 |
0.0169 |
0.0337 |
Multiple synostoses syndrome |
All phenotypes |
(GDF5, HJV) |
1.325 |
0.0467 |
0.157 |
All phenotypes |
(GDF5, NOG) |
1.296 |
0.0194 |
0.157 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, HJV) |
1.325 |
0.0467 |
0.105 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, NOG) |
1.296 |
0.0194 |
0.105 |
Myopathy |
All phenotypes |
(HRAS, RIN1) |
2.049 |
0.0206 |
0.164 |
All phenotypes |
(HRAS, NF1) |
2.003 |
0.0225 |
0.164 |
All phenotypes |
(TPM3, TNNI1) |
1.943 |
0.000602 |
0.0102 |
All phenotypes |
(HRAS, RASA1) |
1.833 |
0.0314 |
0.2 |
All phenotypes |
(HRAS, RASGRF1) |
1.645 |
0.0452 |
0.244 |
All phenotypes |
(DES, KRT20) |
1.523 |
0.000601 |
0.0102 |
All phenotypes |
(KRT37, DES) |
1.478 |
0.000315 |
0.0102 |
All phenotypes |
(DES, KRT33B) |
1.416 |
0.00112 |
0.0142 |
All phenotypes |
(KRT75, DES) |
1.316 |
0.00196 |
0.02 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RIN1) |
2.049 |
0.0206 |
0.185 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, NF1) |
2.003 |
0.0225 |
0.185 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RASA1) |
1.833 |
0.0314 |
0.185 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RASGRF1) |
1.645 |
0.0452 |
0.185 |
Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310] |
(TPM3, TNNI1) |
1.943 |
0.000602 |
0.00361 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT20) |
1.523 |
0.000601 |
0.0021 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT37, DES) |
1.478 |
0.000315 |
0.0021 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT33B) |
1.416 |
0.00112 |
0.0026 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT75, DES) |
1.316 |
0.00196 |
0.00344 |
Myotonia congenita |
All phenotypes |
(CLCN1, CLCN1) |
0.841 |
0.0359 |
0.0359 |
Myotonia congenita, autosomal dominant (MCAD) [MIM:160800] |
(CLCN1, CLCN1) |
1.527 |
0.00631 |
0.00631 |
N-terminal acetyltransferase deficiency |
N-terminal acetyltransferase deficiency (NATD) [MIM:300855] |
(NAA10, NAA15) |
1.515 |
0.0429 |
0.0858 |
Nemaline myopathy |
Nemaline myopathy 1 (NEM1) [MIM:609284] |
(TPM3, TNNI1) |
2.180 |
0.0159 |
0.0159 |
Neu-Laxova syndrome |
Neu-Laxova syndrome 1 (NLS1) [MIM:256520] |
(PHGDH, PHGDH) |
2.753 |
0.022 |
0.022 |
Neuroblastoma |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
(ALK, ALK) |
0.966 |
0.031 |
0.079 |
Neurodevelopmental disorder with brain, liver, and lung abnormalities |
All phenotypes |
(PPP2CA, INTS8) |
4.267 |
2.93e-5 |
0.000674 |
All phenotypes |
(PPP2CA, PTPA) |
2.459 |
0.000788 |
0.00906 |
All phenotypes |
(PPP2CA, PPP2R5C) |
2.313 |
0.00514 |
0.0394 |
All phenotypes |
(PPP2CA, PPME1) |
1.945 |
0.0356 |
0.145 |
All phenotypes |
(ARHGDIB, RAC3) |
1.840 |
0.031 |
0.145 |
All phenotypes |
(PPP2CA, PPP2R5B) |
1.807 |
0.0455 |
0.15 |
All phenotypes |
(ARHGDIA, RAC3) |
1.736 |
0.0379 |
0.145 |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
(PPP2CA, INTS8) |
4.267 |
2.93e-5 |
0.00041 |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
(PPP2CA, PTPA) |
2.459 |
0.000788 |
0.00552 |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
(PPP2CA, PPP2R5C) |
2.313 |
0.00514 |
0.024 |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
(PPP2CA, PPME1) |
1.945 |
0.0356 |
0.124 |
Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354] |
(PPP2CA, PPP2R5B) |
1.807 |
0.0455 |
0.128 |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577] |
(ARHGDIB, RAC3) |
1.840 |
0.031 |
0.114 |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577] |
(ARHGDIA, RAC3) |
1.736 |
0.0379 |
0.114 |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities (NEDCFSA) [MIM:618505] |
(KDM6B, H3C1) |
3.161 |
0.0125 |
0.0125 |
Neurodevelopmental disorder with involuntary movements |
All phenotypes |
(GNAO1, PDE6H) |
3.631 |
2.29e-6 |
6.38e-6 |
All phenotypes |
(GNAO1, PDE6G) |
3.548 |
3.19e-6 |
6.38e-6 |
Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493] |
(GNAO1, PDE6H) |
3.631 |
2.29e-6 |
4.79e-6 |
Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493] |
(GNAO1, PDE6G) |
3.548 |
3.19e-6 |
4.79e-6 |
Neurofibromatosis |
All phenotypes |
(HRAS, NF1) |
3.370 |
4.78e-9 |
1.91e-8 |
All phenotypes |
(KRAS, NF1) |
3.107 |
2.74e-8 |
5.48e-8 |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(HRAS, NF1) |
3.370 |
4.78e-9 |
1.43e-8 |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(KRAS, NF1) |
3.107 |
2.74e-8 |
4.11e-8 |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(NF1, SPRED1) |
4.805 |
0.00187 |
0.00187 |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(HRAS, NF1) |
4.135 |
1.05e-5 |
3.15e-5 |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(KRAS, NF1) |
3.872 |
2.18e-5 |
3.26e-5 |
Neuronopathy |
All phenotypes |
(HSPB6, HSPB8) |
2.523 |
0.00167 |
0.0133 |
All phenotypes |
(HSPB7, HSPB8) |
2.430 |
0.00022 |
0.00352 |
All phenotypes |
(CRYAB, HSPB8) |
2.149 |
0.00453 |
0.0242 |
All phenotypes |
(HSPB2, HSPB8) |
1.606 |
0.0189 |
0.0603 |
All phenotypes |
(CRYAB, HSPB1) |
1.313 |
0.00669 |
0.0268 |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
(HSPB6, HSPB8) |
2.523 |
0.00167 |
0.00417 |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
(HSPB7, HSPB8) |
2.430 |
0.00022 |
0.0011 |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
(CRYAB, HSPB8) |
2.149 |
0.00453 |
0.00755 |
Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590] |
(HSPB2, HSPB8) |
1.606 |
0.0189 |
0.0236 |
Neuronopathy, distal hereditary motor, 2B (HMN2B) [MIM:608634] |
(CRYAB, HSPB1) |
1.313 |
0.00669 |
0.0669 |
Noonan-like syndrome |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2E2) |
3.710 |
0.00832 |
0.0143 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2E3) |
3.710 |
0.00832 |
0.0143 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2D2) |
3.550 |
0.0103 |
0.0143 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(UBC, CBL) |
3.476 |
0.0114 |
0.0143 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2L3) |
3.274 |
0.0149 |
0.0149 |
Noonan syndrome |
All phenotypes |
(RAF1, SFN) |
3.988 |
7.43e-8 |
4.23e-6 |
All phenotypes |
(RAF1, YWHAZ) |
3.503 |
7.27e-7 |
2.07e-5 |
All phenotypes |
(PAK1, RIT1) |
1.967 |
0.0283 |
0.349 |
All phenotypes |
(KRAS, RALGDS) |
1.876 |
0.0403 |
0.349 |
All phenotypes |
(GRB2, PTPN11) |
1.631 |
0.000135 |
0.00257 |
All phenotypes |
(RRAS2, RGL3) |
1.141 |
0.0423 |
0.349 |
Noonan syndrome 12 (NS12) [MIM:618624] |
(RRAS2, RGL3) |
1.141 |
0.0423 |
0.0569 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(GRB2, PTPN11) |
1.631 |
0.000135 |
0.000811 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, RALGDS) |
1.876 |
0.0403 |
0.147 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, SOS1) |
1.302 |
0.00391 |
0.0352 |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1, SFN) |
3.988 |
7.43e-8 |
4.46e-7 |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1, YWHAZ) |
3.503 |
7.27e-7 |
2.18e-6 |
Noonan syndrome 8 (NS8) [MIM:615355] |
(PAK1, RIT1) |
1.967 |
0.0283 |
0.123 |
Obesity |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
(NTRK2, SH2B1) |
5.739 |
0.0187 |
0.0374 |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
(HLA-Cw, KRAS) |
3.217 |
0.0161 |
0.0484 |
Oculoectodermal syndrome (OES) [MIM:600268] |
(KRAS, HLA-C) |
3.217 |
0.0161 |
0.0484 |
Orofacial cleft |
All phenotypes |
(KDM1A, SNAI1) |
4.447 |
9.64e-5 |
0.000492 |
All phenotypes |
(KDM1A, INSM1) |
4.356 |
0.000116 |
0.000492 |
All phenotypes |
(KDM1A, H3-4) |
4.191 |
0.000164 |
0.000492 |
All phenotypes |
(KDM1A, H3C1) |
3.975 |
0.000257 |
0.000567 |
All phenotypes |
(KDM1A, H3-5) |
3.877 |
0.000315 |
0.000567 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, SNAI1) |
4.447 |
9.64e-5 |
0.000273 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, INSM1) |
4.356 |
0.000116 |
0.000273 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3-4) |
4.191 |
0.000164 |
0.000273 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3C1) |
3.975 |
0.000257 |
0.000315 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3-5) |
3.877 |
0.000315 |
0.000315 |
Osteogenesis imperfecta |
All phenotypes |
(COL3A1, SPARC) |
3.777 |
0.00532 |
0.0319 |
All phenotypes |
(COL1A1, GP6) |
2.862 |
0.00201 |
0.0241 |
All phenotypes |
(COL1A1, COL9A3) |
1.199 |
0.0255 |
0.0829 |
All phenotypes |
(COL1A1, COL9A1) |
1.175 |
0.0276 |
0.0829 |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
(COL3A1, SPARC) |
3.777 |
0.00532 |
0.00532 |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
(COL1A1, FN1) |
3.787 |
0.000769 |
0.00462 |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
(COL1A1, GP6) |
3.386 |
0.000473 |
0.00331 |
Ovarian cancer |
Ovarian cancer (OC) [MIM:167000] |
(HLA-A, CTNNB1) |
5.072 |
0.000884 |
0.00619 |
Ovarian cancer (OC) [MIM:167000] |
(CTNNB1, BTRC) |
4.860 |
0.0341 |
0.0796 |
Ovarian cancer (OC) [MIM:167000] |
(BRCA1, BRIP1) |
2.816 |
0.0252 |
0.0796 |
Ovarian dysgenesis |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(ESR2, NCOA3) |
4.741 |
0.0374 |
0.0611 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(NCOA2, ESR2) |
4.741 |
0.0374 |
0.0611 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(ESR2, NCOA5) |
4.519 |
0.0436 |
0.0611 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(ESR2, PPARGC1A) |
4.519 |
0.0436 |
0.0611 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(NRIP1, ESR2) |
4.519 |
0.0436 |
0.0611 |
Pachyonychia congenita |
All phenotypes |
(KRT6A, LMNA) |
2.002 |
2.27e-5 |
0.000839 |
All phenotypes |
(KRT34, KRT6A) |
1.729 |
0.000113 |
0.00105 |
All phenotypes |
(KRT38, KRT6A) |
1.729 |
0.000113 |
0.00105 |
All phenotypes |
(KRT6A, KRT35) |
1.704 |
0.000131 |
0.00105 |
All phenotypes |
(KRT6A, KRT40) |
1.680 |
0.000151 |
0.00105 |
All phenotypes |
(KRT6A, KRT31) |
1.633 |
0.000198 |
0.00105 |
All phenotypes |
(KRT6A, KRT16) |
1.572 |
0.000172 |
0.00105 |
All phenotypes |
(KRT6A, KRT17) |
1.284 |
0.00103 |
0.00477 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, LMNA) |
2.002 |
2.27e-5 |
0.000204 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT34, KRT6A) |
1.729 |
0.000113 |
0.000271 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT38, KRT6A) |
1.729 |
0.000113 |
0.000271 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT35) |
1.704 |
0.000131 |
0.000271 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT40) |
1.680 |
0.000151 |
0.000271 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT31) |
1.633 |
0.000198 |
0.000297 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT17) |
1.610 |
0.000842 |
0.00108 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT16) |
1.559 |
0.00108 |
0.00122 |
Parkinson disease |
All phenotypes |
(SNCA, PPIA) |
2.959 |
0.0227 |
0.373 |
All phenotypes |
(PLA2G6, PLA2G6) |
2.385 |
0.0367 |
0.373 |
Parkinson disease 14 (PARK14) [MIM:612953] |
(PLA2G6, PLA2G6) |
2.385 |
0.0367 |
0.0367 |
Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601] |
(SNCA, PPIA) |
2.959 |
0.0227 |
0.0682 |
Parkinson disease 2 (PARK2) [MIM:600116] |
(PRKN, STAMBP) |
1.576 |
0.0428 |
0.531 |
Periventricular heterotopia |
All phenotypes |
(UBA52, NEDD4L) |
2.603 |
0.0363 |
0.218 |
Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201] |
(UBA52, NEDD4L) |
2.603 |
0.0363 |
0.109 |
Peroxisome biogenesis disorder |
Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862] |
(PEX1, PEX6) |
2.447 |
0.0336 |
0.0336 |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
(FGF1, FGFR1) |
4.347 |
0.0492 |
0.171 |
Pheochromocytoma |
Pheochromocytoma (PCC) [MIM:171300] |
(RET, LRRK1) |
5.200 |
0.0272 |
0.218 |
Pheochromocytoma (PCC) [MIM:171300] |
(RET, MAPK1) |
4.986 |
0.0316 |
0.218 |
Pheochromocytoma (PCC) [MIM:171300] |
(RET, MAPK3) |
4.937 |
0.0326 |
0.218 |
Piebaldism |
Piebald trait (PBT) [MIM:172800] |
(KIT, KIT) |
1.178 |
0.0487 |
0.304 |
Pilomatrixoma |
Pilomatrixoma (PTR) [MIM:132600] |
(CTNNB1, BTRC) |
5.182 |
8.11e-8 |
1.22e-7 |
Pilomatrixoma (PTR) [MIM:132600] |
(CTNNB1, FBXW11) |
5.097 |
7.07e-5 |
7.07e-5 |
Pilomatrixoma (PTR) [MIM:132600] |
(HLA-A, CTNNB1) |
5.072 |
6.11e-13 |
1.83e-12 |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, TCF4) |
1.447 |
0.00013 |
0.0039 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID3) |
1.276 |
0.0209 |
0.226 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID2) |
1.165 |
0.0302 |
0.226 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID4) |
1.165 |
0.0302 |
0.226 |
Pontocerebellar hypoplasia |
All phenotypes |
(EXOSC9, EXOSC3) |
2.713 |
0.00665 |
0.0532 |
Prostate cancer |
Prostate cancer (PC) [MIM:176807] |
(RNF8, CHEK2) |
2.177 |
0.00302 |
0.0151 |
Pseudohypoaldosteronism |
All phenotypes |
(KLHL2, WNK4) |
5.256 |
1.79e-5 |
7.18e-5 |
All phenotypes |
(WNK4, KLHL3) |
3.081 |
1.63e-7 |
1.3e-6 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(WNK4, KLHL3) |
5.408 |
1.31e-5 |
1.79e-5 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(KLHL2, WNK4) |
5.256 |
1.79e-5 |
1.79e-5 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK4, KLHL3) |
2.414 |
0.000267 |
0.00145 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK3, KLHL3) |
2.230 |
0.000576 |
0.00145 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(KEAP1, KLHL3) |
2.173 |
0.000726 |
0.00145 |
Pseudohypoparathyroidism |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
(GNAS, ADCY2) |
2.484 |
0.0453 |
0.181 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GHRHR) |
4.200 |
0.00296 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, CRHR2) |
4.133 |
0.00325 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(VIPR1, GNAS) |
4.133 |
0.00325 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CALCR, GNAS) |
3.949 |
0.00419 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CRHR1, GNAS) |
3.949 |
0.00419 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADORA2A, GNAS) |
3.892 |
0.00454 |
0.0129 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, CALCRL) |
3.734 |
0.00564 |
0.0137 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTGER4, GNAS) |
3.548 |
0.00731 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(SCTR, GNAS) |
3.423 |
0.0087 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR52) |
3.383 |
0.00919 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADCYAP1R1, GNAS) |
3.345 |
0.00969 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GCGR, GNAS) |
3.235 |
0.0113 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GLP1R, GNAS) |
3.200 |
0.0118 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPBAR1) |
3.200 |
0.0118 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(DRD1, GNAS) |
2.949 |
0.0168 |
0.019 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADRB2, GNAS) |
2.865 |
0.0189 |
0.02 |
Pyridoxine-5'-phosphate oxidase deficiency |
Pyridoxine-5'-phosphate oxidase deficiency (PNPOD) [MIM:610090] |
(PNPO, PNPO) |
1.675 |
0.0307 |
0.0307 |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1, SPTB) |
5.465 |
0.0226 |
0.0453 |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1, SPTBN1) |
4.408 |
0.0471 |
0.0471 |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
(INSR, GRB10) |
2.471 |
0.0492 |
0.156 |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
(INSR, IRS1) |
2.471 |
0.0492 |
0.156 |
Radioulnar synostosis with amegakaryocytic thrombocytopenia |
Thrombocytopenia 6 (THC6) [MIM:616937] |
(SRC, PTPN1) |
6.016 |
0.0155 |
0.0618 |
Renal cell carcinoma |
All phenotypes |
(SH2B2, MET) |
5.104 |
2.37e-7 |
9.83e-7 |
All phenotypes |
(MET, SH2B1) |
4.967 |
3.78e-7 |
9.83e-7 |
All phenotypes |
(MET, SH2B3) |
4.967 |
3.78e-7 |
9.83e-7 |
All phenotypes |
(MET, TXK) |
2.903 |
6.24e-8 |
8.12e-7 |
All phenotypes |
(MET, TEC) |
2.782 |
1.38e-7 |
8.99e-7 |
All phenotypes |
(MET, BTK) |
2.357 |
0.000173 |
0.000374 |
All phenotypes |
(MET, ITK) |
2.339 |
0.00213 |
0.00396 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(SH2B2, MET) |
5.104 |
2.37e-7 |
9.07e-7 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, SH2B1) |
4.967 |
3.78e-7 |
9.07e-7 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, SH2B3) |
4.967 |
3.78e-7 |
9.07e-7 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, TXK) |
2.903 |
6.24e-8 |
7.49e-7 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, TEC) |
2.782 |
1.38e-7 |
8.3e-7 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, BTK) |
2.357 |
0.000173 |
0.000346 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, ITK) |
2.339 |
0.00213 |
0.00365 |
Retinitis pigmentosa |
All phenotypes |
(PRPF6, PRPF6) |
6.290 |
0.0128 |
0.0809 |
All phenotypes |
(PRPF3, PRPF8) |
4.750 |
0.00138 |
0.0131 |
All phenotypes |
(SNRNP200, PRPF8) |
2.642 |
0.000943 |
0.0131 |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
(SNRNP200, PRPF8) |
3.909 |
7.72e-5 |
7.72e-5 |
Retinitis pigmentosa 18 (RP18) [MIM:601414] |
(PRPF3, PRPF8) |
4.750 |
0.00138 |
0.00138 |
Retinitis pigmentosa 60 (RP60) [MIM:613983] |
(PRPF6, PRPF6) |
6.290 |
0.0128 |
0.0128 |
Richieri-Costa-Pereira syndrome |
Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305] |
(EIF4A3, UPF3B) |
4.911 |
0.0332 |
0.0665 |
SHORT syndrome |
All phenotypes |
(PIK3R1, SYK) |
4.958 |
0.0319 |
0.339 |
SHORT syndrome (SHORTS) [MIM:269880] |
(PIK3R1, SYK) |
4.958 |
0.0319 |
0.16 |
Severe combined immunodeficiency |
All phenotypes |
(B2M, TRA) |
4.498 |
0.0442 |
0.278 |
All phenotypes |
(LCK, ZAP70) |
2.885 |
0.0271 |
0.278 |
Immunodeficiency 43 (IMD43) [MIM:241600] |
(B2M, TRA) |
4.498 |
0.0442 |
0.0442 |
Immunodeficiency 48 (IMD48) [MIM:269840] |
(LCK, ZAP70) |
2.885 |
0.0271 |
0.0541 |
Shprintzen-Goldberg craniosynostosis syndrome |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
(SKI, SMAD2) |
3.402 |
6.29e-12 |
6.29e-12 |
Sialuria |
Sialuria (SIALURIA) [MIM:269921] |
(GNE, GNE) |
2.356 |
0.00745 |
0.00745 |
Sick sinus syndrome |
All phenotypes |
(HCN4, HCN4) |
1.599 |
0.036 |
0.108 |
Sick sinus syndrome 2 (SSS2) [MIM:163800] |
(HCN4, HCN4) |
1.599 |
0.036 |
0.036 |
Spastic paraplegia |
All phenotypes |
(SPAST, SPAST) |
0.625 |
0.000566 |
0.00396 |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
(SPAST, SPAST) |
0.625 |
0.000566 |
0.000566 |
Spermatogenic failure |
Spermatogenic failure 10 (SPGF10) [MIM:614822] |
(SEPTIN12, SEPTIN1) |
2.276 |
0.0427 |
0.299 |
Spinal muscular atrophy |
All phenotypes |
(DYNC1I2, DYNC1H1) |
3.206 |
0.0182 |
0.0726 |
All phenotypes |
(SMN1, SMN1) |
2.091 |
0.00451 |
0.0361 |
Spinal muscular atrophy 1 (SMA1) [MIM:253300] |
(SMN1, SMN1) |
2.676 |
0.033 |
0.033 |
Spinal muscular atrophy 3 (SMA3) [MIM:253400] |
(SMN1, SMN1) |
2.091 |
0.0281 |
0.0562 |
Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600] |
(DYNC1I2, DYNC1H1) |
3.206 |
0.0182 |
0.0363 |
Spinocerebellar ataxia |
All phenotypes |
(AFG3L2, AFG3L2) |
1.275 |
7.97e-5 |
0.000717 |
Spinocerebellar ataxia 28 (SCA28) [MIM:610246] |
(AFG3L2, AFG3L2) |
1.275 |
7.97e-5 |
7.97e-5 |
Split-hand/foot malformation |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
(PPP1R13L, TP63) |
3.824 |
0.00644 |
0.0126 |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
(TP53BP2, TP63) |
3.631 |
0.00838 |
0.0126 |
Symphalangism |
All phenotypes |
(BMP2, NOG) |
2.014 |
0.00108 |
0.00592 |
All phenotypes |
(BMP7, NOG) |
1.892 |
0.00171 |
0.00628 |
All phenotypes |
(GDF5, NOG) |
1.670 |
0.000623 |
0.00592 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(BMP2, NOG) |
2.014 |
0.00108 |
0.00228 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(GDF5, NOG) |
1.972 |
0.00126 |
0.00228 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(BMP7, NOG) |
1.892 |
0.00171 |
0.00228 |
Tangier disease |
Tangier disease (TGD) [MIM:205400] |
(ABCA1, ABCA12) |
3.725 |
0.01 |
0.01 |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(BMP2, NOG) |
2.599 |
0.0045 |
0.00579 |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(GDF5, NOG) |
2.557 |
0.0049 |
0.00579 |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(BMP7, NOG) |
2.477 |
0.00579 |
0.00579 |
Temple-Baraitser syndrome |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, CALM2) |
5.243 |
0.0262 |
0.0349 |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, KCNC1) |
3.207 |
0.0149 |
0.0349 |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, KCNF1) |
3.010 |
0.0194 |
0.0349 |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, KCNB1) |
2.456 |
0.0407 |
0.0407 |
Thanatophoric dysplasia |
All phenotypes |
(FGFR3, FGFR3) |
1.970 |
0.011 |
0.0767 |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGF1, FGFR3) |
2.420 |
0.0492 |
0.146 |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGFR3, FGFR3) |
1.777 |
0.044 |
0.146 |
Thyroid dyshormonogenesis |
All phenotypes |
(THRB, NCOA2) |
1.513 |
0.0289 |
0.26 |
Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
(THRB, NCOA2) |
1.604 |
0.0225 |
0.18 |
Trichothiodystrophy |
All phenotypes |
(ERCC2, GTF2H2C) |
2.856 |
0.00181 |
0.00725 |
All phenotypes |
(ERCC2, GTF2H2) |
2.415 |
0.00547 |
0.0109 |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
(ERCC2, GTF2H2C) |
2.856 |
0.00181 |
0.00544 |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
(ERCC2, GTF2H2) |
2.415 |
0.00547 |
0.0082 |
Usher syndrome |
Usher syndrome 1D/F (USH1DF) [MIM:601067] |
(CDH23, USH1C) |
5.485 |
0.0223 |
0.0223 |
Von Hippel-Lindau disease |
Von Hippel-Lindau disease (VHLD) [MIM:193300] |
(VHL, ELOC) |
0.779 |
0.000513 |
0.00462 |
Von Willebrand disease |
All phenotypes |
(VWF, GP1BA) |
1.773 |
0.00387 |
0.0155 |
Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
(VWF, GP1BA) |
2.817 |
0.00286 |
0.00572 |
Von Willebrand disease 2 (VWD2) [MIM:613554] |
(VWF, GP1BA) |
1.954 |
0.0191 |
0.0573 |
Waardenburg syndrome |
Waardenburg syndrome 1 (WS1) [MIM:193500] |
(POU3F2, PAX3) |
1.171 |
0.0275 |
0.055 |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
(EZH2, WDR61) |
4.563 |
0.00311 |
0.0155 |
Weaver syndrome (WVS) [MIM:277590] |
(EZH2, JARID2) |
2.797 |
0.0322 |
0.0556 |
Weaver syndrome (WVS) [MIM:277590] |
(EED, EZH2) |
1.336 |
0.0334 |
0.0556 |
Wilms tumor |
All phenotypes |
(DICER1, DICER1) |
5.511 |
0.000481 |
0.000962 |
Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272] |
(DICER1, DICER1) |
5.511 |
0.000481 |
0.000481 |
Xeroderma pigmentosum |
All phenotypes |
(ERCC2, GTF2H1) |
1.334 |
0.00759 |
0.0683 |
Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
(ERCC2, GTF2H1) |
1.334 |
0.00759 |
0.0304 |
Zimmermann-Laband syndrome |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
(KCNH1, KCNF1) |
3.332 |
2.17e-5 |
6.5e-5 |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
(KCNH1, KCNC1) |
3.207 |
0.000362 |
0.000542 |
[Show all]
(**) All phenotypes refers to the union of mutations related to any phenotype of the same disease.
|